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ABSTRACT 
The combination of manmade materials and biological components to form perchlorate-
reducing vesicles may address several of the limitations associated with current perchlorate 
treatment technologies. The vesicles have a membrane comprised of the synthetic polymer, 
PMOXA-PDMS-PMOXA (ABA), which is stable over several months and is able to incorporate 
membrane proteins such as the outer membrane pores (OmpF). As the vesicles are formed, they 
can encapsulate perchlorate-reducing enzymes such as perchlorate reductase (Pcr) and chlorite 
dismutase (Cld).  
 
 To investigate the use of the vesicles in the treatment of perchlorate, polymer vesicles 
were formed with and without OmpF using the film-hydration method. Lipid vesicles were also 
tested. The size and size distribution of the vesicles was determined using dynamic light 
scattering and transmission electron microscopy. The perchlorate-reducing activity of the 
vesicles was determined using a colorimetric methyl viologen assay. The activity of the enzymes 
was assessed in oxygen and oxygen free environments, in 10% glycerol, and in the presence of 
protease and protease inhibitors. The activity of the enzymes toward similar anions such as 
nitrate and sulfate were determined with a UV-absorbance NADH assay and endpoint analysis 
using capillary electrophoresis.  
 
 The lipid and polymer vesicles demonstrated similar abilities to reduce perchlorate. 
Perchlorate-reducing activity was higher in vesicles with OmpF versus vesicles without OmpF. 
The activity of the enzymes showed no deterioration in the presence of oxygen versus non-
oxygen environments. Addition of 10% glycerol proved to be an effective stabilizing agent for 
enzyme activity. Protease treatment of the enzymes resulted in partial enzyme inactivation. 
Protease inhibitors afforded no protective effects and even decreased activity. Enzymes had 
activity with nitrate but not sulfate. Perchlorate and nitrate competed for limited electron donor; 
however, the enzymes’ affinity for perchlorate was much higher than nitrate.  
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 The polymer and lipid vesicles demonstrate perchlorate-reducing capabilities in drinking 
water relevant conditions. With optimization, the vesicles show potential to compete with current 
treatment technologies for perchlorate. More broadly, the application of the treatment technology 
could be applied to any type of contaminant in which there are microbial degrading enzymes. 
Enzymes are also not limited to a specific set.  Multiple contaminant-degrading enzymes could 
be encapsulated at various ratios to achieve flexible treatment. The flexibility of this treatment 
could lead to contaminant-tailored treatment options for drinking water facilities.  
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CHAPTER 1 - INTRODUCTION:  
 
Evolution of the processes for water purification has led to higher quality and larger 
quantities of treated water; however, water remains to this day an integral component of society. 
The quality and quantity of our drinking water is continually threatened by numerous factors 
including weather, contamination, accessibility and excessive use [1]. These threats have resulted 
in recent shortages in the southeast and western regions of the United States. Recent shortages 
have demonstrated a need to conserve and protect limited supplies. 
 
To protect our water supplies, I focus my research on the 
remediation of the contaminant perchlorate. The structure of 
perchlorate includes a central chloride anion surrounded by four 
oxygen atoms with a size of approximately 3.5 angstroms (Figure 
1).  Perchlorate carries a negative charge and in solid form is 
typically associated with a hydrogen ion or another monovalent 
cation such as ammonium, potassium, or sodium. Aqueous 
perchlorate dissociates readily. Perchlorate is extremely stable in 
the environment due to its high activation energy. Due to its 
stability and with an estimated 15.9 million kilograms of 
perchlorate introduced into the environment due to rocket, munitions, and missile use, 
perchlorate-contaminated drinking water has been detected throughout the United States using 
advanced analytical methods with an average range of 5 to 20 parts per billion [2, 3]. Of great 
concern, perchlorate contamination of groundwater at 600 mg/L has been found at military and 
industrial sites [4]. These elevated concentrations are similar to pharmacological treatment doses 
used in the 1950’s [5]. Perchlorate has also been introduced into the environment through the 
application of nitrate fertilizers harvested from Chile, where naturally occurring perchlorate-
contaminated soil results in drinking water contamination exceeding 100 µg/L [6].   
 
Figure 1: Chemical 
structure of the 
oxyanion perchlorate. 
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 Perchlorate contamination of drinking waters is a growing concern with the development 
of advanced detection capabilities. These advanced techniques detect perchlorate contamination 
at parts per billion concentrations. At these low concentrations, scientists have begun to analyze 
the potential health effects on humans. Perchlorate affects human health by accumulating in the 
thyroid, resulting in iodide deficiency. The thyroid uses a sodium-iodide symporter to transport 
iodide into the thyroid, concentrating iodide at several orders of magnitude higher concentrations 
than the outside environment [7]. However, perchlorate uptake by the sodium iodide symporter 
is 30 times faster than the uptake rate of iodide [8]. Perchlorate interrupts the proper function of 
the thyroid which is essential to good health. The thyroid acts as a throttle for mammals, 
controlling several systems such as metabolic rate, production of proteins, rate of growth and the 
body’s sensitivity to other hormones. The thyroid regulates these processes by producing 
hormones, predominantly triiodothyronine (T3) and thyroxine (T4). Iodide deficiency results in 
stunted growth and even mental retardation in fetuses and young children. In adults, iodide 
deficiency has been linked to hypothyroidism with common symptoms of fatigue, weight gain or 
difficulty losing weight, and muscle cramps [9].  
 
These health effects arise from even short term or low dose exposure. Lamm et al. 
established a no-observed-adverse-effect-level (NOAEL) of absorbed perchlorate concentrations 
of 34 mg/day for adults [10]. Another study, from northern Chile, examined the effects of three 
perchlorate concentration ranges, 100 to 120 μg/L, 5 to 7 μg/L and <4 μg/L, on school children 
and newborns. Overall, the research claimed no observed suppressed thyroid function in 
newborns and school-age children from exposure to these dosages [6]. Large pharmacological 
doses in the range of 200 to upwards of 1200 mg/day were used in the 1950s to treat iodide-
induced hyperthyroidism with successful results. Radioactive perchlorate inhibits the uptake of 
radioactive iodide into the thyroid [5]. However, few studies have directly measured the effects 
of perchlorate on sensitive populations within the United States [11]. 
 
Based on these studies, the Environmental Protection Agency (EPA) has decided to 
regulate perchlorate under the Safe Drinking Water Act. Initial assessments have recommended 
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perchlorate concentrations in drinking waters be limited to 15 μg/L [12, 13]. Once the EPA 
enacts a national drinking water standard, demand for perchlorate treatment will dramatically 
increase [14, 15]. Currently, some water facilities already treat for perchlorate using ion 
exchange or reverse osmosis. Demand for perchlorate treatment stems from increasingly strict 
state drinking water standards such as those in Massachusetts and the public perception of 
perchlorate’s health effects [16]. 
 
The focus of my 
research is the 
development of a novel 
perchlorate remediation 
technology. This 
technology, called 
synthetic perchlorate 
reducing vesicles, 
combines manmade 
material and biological 
components. As shown 
in Figure 2, ABA 
polymer mimics cellular 
membranes and allows 
for the insertion of the 
biological Escherichia 
coli transport protein, 
outer membrane pore 
(OmpF). Perchlorate-
degrading enzymes, 
perchlorate reductase 
Figure 2: Synthetic Perchlorate Reducing Vesicle.  
(1) One promising method for removing perchlorate from water is 
the use of PMOXA-PDMS-PMOXA ABA tri-block copolymer 
synthetic vesicles.  (2) These synthetic vesicles mimic biological 
membranes by inserting pores such as OmpF, allowing perchlorate 
to diffuse into the vesicle. (3) Perchlorate-reducing enzymes, 
perchlorate reductase and chlorite dismutase, encapsulated in the 
vesicle degrade perchlorate into chloride and oxygen. 
 
4 
 
(Pcr) and chlorite dismutase (Cld), are encapsulated inside the vesicle. Perchlorate diffuses 
through the transmembrane pore into the vesicle. Once inside, perchlorate is degraded by the 
enzymes.  
 
The vesicles are comprised of triblock copolymers that mimic the spherical structure of 
cell membranes with exterior hydrophilic and interior hydrophobic groups [17]. The polymer 
structure is poly-(2-methyloxazoline)-poly-(dimethylsiloxane)-poly-(2-methyloxazoline) 
(PMOXA15-PDMS110-PMOXA15) (ABA) (Figure 3). The polymer has been shown to 
successfully insert other membrane proteins such as aquaporins and ATP synthase [18, 19]. ABA 
polymers naturally form vesicles, with the size of the vesicles dependent on the characteristics of 
the polymer’s hydrophilic and hydrophobic block lengths [20]. These vesicles’ wall on average 
is much thicker than liposome’s walls and can range from 8-21 nm [21]. The stability of the 
vesicles is important for the long term use in water treatment. The vesicles’ stability was studied 
using a variety of methods including size, size distribution, and permeability [22]. Permeability 
was measured using stopped-flow analysis and polymer vesicles showed less permeability than 
lipid vesicles [22]. For polymer vesicles in a water treatment relevant environment, the vesicles 
demonstrated stable size and size distribution for over a year.  
 
 
Figure 3: Chemical structure of the ABA polymer.  
The polymer consists of repeating units of PMOXA and PDMS. Repeating units are indicated in 
brackets with x representing the number of PMOXA subunits and y PDMS subunits. Structures 
connecting the repeating units are referred to as blocks.  
 
In addition to the polymer stability, vesicles offer other advantages over biological 
cultures. Perchlorate can be remediated by biological cultures; however, degradation is often 
limited by the presence of other electron acceptors such as oxygen and nitrate [23, 24]. Using 
contaminant-specific enzymes, the need for an anaerobic condition can be circumvented. Also, 
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as the vesicles are inert material, using the vesicles in drinking water applications may avoid the 
regulatory concerns associated with genetically modified organisms.  
 
Introduction Summary: This thesis investigated the use of the perchlorate-reducing enzymes, 
perchlorate reductase and chlorite dismutase, in synthetic vesicles for treatment of perchlorate-
contaminated water. The Literature Review details current treatment techniques for perchlorate 
remediation.  These remediation techniques are classified into two categories, perchlorate 
separation and degradation technologies. The final treatment technology, biological reduction, 
segues into the discussion of perchlorate-reducing strain Azospira oryzae, the perchlorate-
reducing enzymes’ structure and capabilities, the enzyme purification, and our attempts at 
overexpression of the enzymes. The Materials and Methods outlines the procedures used to 
produce perchlorate-reducing vesicles and their analysis. Data is presented beginning with 
enzyme stability and anion degradation abilities followed by vesicles. The Discussion interprets 
the data to answer the hypothesis that synthetic perchlorate-reducing vesicles are capable of 
preferentially reducing perchlorate. 
  
  
6 
 
CHAPTER 2 - LITERATURE REVIEW 
 
The first section of this literature review focuses on current treatment technologies for 
perchlorate-contaminated drinking water. By studying current perchlorate treatment 
technologies, limitations and difficulties associated with perchlorate treatment are elucidated. 
This information is utilized in this thesis to develop a perchlorate treatment technology that 
circumvents many of the current limitations. The final treatment technology, biological 
reduction, segues into the second section of the literature review, the biological enzymes 
responsible for perchlorate reduction. By studying the enzymes responsible for perchlorate 
degradation, information such as enzyme kinetics, enzyme requirements and anion competition 
can be optimized to improve the performance of synthetic perchlorate-reducing vesicles.  
 
2.1: CURRENT TREATMENT TECHNOLOGIES FOR THE REMOVAL OF 
PERCHLORATE IN DRINKING WATERS. 
 
With the recent announcement of the U.S. Environmental Protection Agency’s intent to 
regulate perchlorate in drinking waters [25], research into drinking water detection and removal 
of perchlorate has increased.  While no regulatory maximum contaminant level has been issued 
yet, it is anticipated that drinking water facilities throughout the United States may need to begin 
treating for perchlorate-contaminated waters.  Several technologies are used to treat perchlorate-
contaminated drinking water. These technologies are often divided into two categories: 
perchlorate separation and perchlorate degradation.  Perchlorate separation technologies include 
granular activated carbon (GAC), membranes, and ion exchange, and their general function is 
described as pulling perchlorate anions out of drinking water.  Technologies that degrade 
perchlorate include chemical and biological reduction and are defined by changing perchlorate 
into chloride in drinking water [26, 27].  In the following sections, I will outline the basic design 
and operation of each approach for the treatment of perchlorate in drinking waters. 
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2.1.1 Perchlorate Separation Technologies: 
 
2.1.1.1 Granular Activated Carbon (GAC) – Absorption of contaminants into GAC is 
common throughout drinking water facilities in the United States. GAC typically used in 
drinking water facilities is a hydrophobic carbon compound. Due to its hydrophobic nature, 
activated carbon is typically used for non-volatile organic compounds. Activated carbon contains 
pores that contaminants enter and are trapped.  The activated carbon is then removed for disposal 
or regeneration. Perchlorate, an inorganic anion, is generally not a candidate for treatment using 
virgin GAC. Using GAC technologies for the treatment of perchlorate requires that the GAC be 
altered into a more hydrophilic compound.   
 
 Modified GAC has been shown to successfully sorb perchlorate.  Modifications of the 
GAC surface have included cetyltrimethylammonium chloride, iron oxalic acid and increasing 
the nitrogen content of GAC with ammonia [28-31].  These modifications increase the absorptive 
capacity of GAC and the breakthrough time for perchlorate. Despite the improvements in 
perchlorate sorption, the modifications are not without drawbacks. By altering GAC to sorb 
perchlorate, the carbon is susceptible to all inorganic anions.  Also, organic non-volatiles are no 
longer sorbed to the activated carbon.  Activated carbon also suffers drawbacks common in all 
perchlorate separation technology, including problems with regenerating the media and 
destruction of the concentrated perchlorate waste.  
 
2.1.1.2 Membranes – Membrane technology relies on the use of a semi-permeable membrane 
that rejects the passage of molecules based on their physical properties such as size and polarity.  
Membranes are categorized by their pore structure, with the following names decreasing in pore 
size: microfiltration, ultrafiltration, nanofiltration and reverse osmosis. For smaller-pored 
membranes such as nanofiltration and reverse osmosis, water pressure is elevated on the influent 
side of the membrane compared to traditional drinking water treatment facilities to overcome the 
osmotic pressure barrier.  Contaminants concentrate on the influent side of the membrane.  Once 
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membranes become fouled, the membrane is washed and the contaminants are removed as a 
concentrated waste. For the anion perchlorate, microfiltration and ultrafiltration membranes are 
insufficient for perchlorate removal based on the anion size.  Nanofiltration is capable of 
separating perchlorate from drinking water; however, reverse osmosis membranes have the 
highest perchlorate rejection rates [32].  
 
 For perchlorate removal from drinking water, membrane technologies have focused on 
two approaches. The first involves increasing the size of perchlorate through the use of polymers.  
Specialized polymers bind to perchlorate, increasing its diameter.  This increased diameter 
prevents the passage of perchlorate through large-pored membranes such as ultra and 
microfiltration membranes [33, 34].  The other approach for perchlorate removal is the hindered 
diffusion of perchlorate through small-pored membranes such as nanofiltration and reverse 
osmosis. The small pore sizes and the amide bonds of the polymer membrane allow water to 
diffuse much more quickly across the membrane than perchlorate [35, 36].  A similar treatment 
relies on electricity rather than pressure to remove perchlorate: electrodialysis. This technique 
combines small-pored membranes that are cationic or anionic selective with an electrical current.  
Electrical current is applied to the water and perchlorate accumulates on the anionic selective 
membrane [26]. 
 
 Despite the use of membrane technologies in drinking water treatment, the membranes 
suffer from numerous complications. The first method of perchlorate removal uses polymers 
which can be expensive and introduce unknown contaminants into drinking water. The second 
membrane method requires the use of pressure and electricity which increases the cost of 
perchlorate treatment. All of these approaches also generate large amounts of concentrated 
wastes that require additional treatment.   
 
2.1.1.3 Ion Exchange – The basic principle of ion exchange is the introduction of a similar 
cation or anion into the drinking water in exchange for the target contaminant such as 
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perchlorate. This is accomplished by passing water through a column suitable for trapping ions.  
Ion exchange columns contain a variety of media, with most commercial columns containing 
organic polymers, such as polystyrene strands cross-linked by the addition of divinylbenzene.  
Other media includes zeolites, clay and humus.  Media can be made mono or bifunctional.  
Bifunctional resins work to target a specific type of ions.   
 
 Varying functional groups are added to the polystyrene resin depending on the targeted 
contaminant.  Functional groups are classified into four types: strongly acidic or basic or weakly 
acidic or basic.  Strongly acidic and basic functional groups include sulfonic acid groups and 
quaternary ammonium groups respectively.  For weakly acidic and basic functional groups, 
carboxylic acid groups and primary, secondary, or tertiary amino groups are used respectively.  
The resins are charged with innocuous or less hazardous ions that will be exchanged for the 
target contaminant.  For anion exchange, resins are generally charged with hydroxide ions, 
monovalent anions, or polyvalent anions.   
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  The ion exchange process is similar for perchlorate treatment (Figure 4). However, 
treatment of perchlorate with ion exchange columns is often inefficient for two reasons. First, 
perchlorate in drinking water is in extremely low concentrations [26]. Second, several anions 
compete with perchlorate for resin sites.  These anions include nitrate, chloride, sulfate and 
bicarbonate. Also, these competing anions are often at higher concentrations in drinking water 
than perchlorate [26].  
 
To design an ion exchange system that effectively treats for perchlorate, resins were 
created to have a high selectivity (Kd) for perchlorate.  The selectivity was created using a 
bifunctional resin with quaternary ammonium groups with long and short chains [37].  The long 
chains prevent larger anions such as nitrate and sulfate from interacting with the resin. 
Perchlorate, with low hydration energy, is sufficiently small to interact with the resin.  The 
shorter chains increase the binding kinetics of perchlorate.   
 
Figure 4: Ion Exchange Process for Perchlorate.  
The above figure is an ion exchange process with perchlorate and other competing anions.  A 
column filled with small clean resin beads (on the left) receives contaminated water.  This 
water contains anions such as nitrate, sulfate, perchlorate, chloride and bicarbonate. These 
contaminants exchange places with chloride from the clean beads.  Eventually, all beads in the 
column become saturated with non-chloride anions and must be regenerated or replaced for the 
system to continue removing anions. 
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 Over time, the functional sites of the resins become saturated with the target contaminant. 
Once the functional sites are saturated, perchlorate breakthrough will occur and target 
contaminant will appear in the effluent.  Ion exchange columns can be recharged to prevent 
breakthrough.  Regeneration of ion exchange columns occurs in three steps: backwashing, 
regeneration, and rinsing. 
 
 With the development of strong perchlorate-selective bifunctional resins, a new 
regeneration solution had to be developed since traditional anions such as chloride were unable 
to remove perchlorate.  Scientists developed a two-step regeneration method involving anion 
displacement followed by an oxidation-reduction reaction. Tetrachloroferrate, a similar anion to 
perchlorate, was used to displace perchlorate from the resin [38].  Once the resin was saturated 
with the tetrachloroferrate, hydrochloric acid was used, causing the iron to release chloride.  
After two or more chlorides were released from the tetrachloroferreate, the compound became 
positively charged and dissociated from the resin due to charge repulsion.  Chloride was then 
allowed to occupy and regenerate the resin.  Single-use perchlorate selective resins have also 
successfully been used in the treatment of drinking water [39]. 
 
 While ion exchange is a viable option for perchlorate treatment, several factors limit the 
effectiveness of the treatment.  This includes competition of similar anions, including common 
anions such as sulfate and nitrate but also pentavalent arsenic, hexavalent selenium, and 
hexavalent chromium. Radionuclides such as uranium may also compete with ion exchange sites 
[40].  Another factor is the treatment of the concentrated wastes resulting from ion-exchange 
drinking water treatment.  Treatment of the wastes is expensive involving high-energy processes 
including incineration and thermo-chemical conversion of the contaminants [41].  Alternative 
waste treatments such as microbial degradation have been developed but are also costly due to 
nutrient requirements of the bacteria.  
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2.1.2 Perchlorate Degradation Technologies: 
 
2.1.2.1 Chemical Reduction – Chemical reduction of perchlorate is carried out through the 
transfer of eight electrons to the central chloride atom.  Perchlorate is a strong oxidizing agent 
used in rocket fuels and munitions.  Its degradation is thermodynamically favorable. However, 
perchlorate in the environment is very stable likely from the large kinetic energy required to 
provide the initial activation energy.  This kinetic barrier is likely due to the inability to access 
the central chloride atom because of the surrounding four oxygen atoms in the tetrahedral 
structure.  
 
 Several studies have focused on the use of catalysts to decrease the activation energy 
required to degrade perchlorate.  These catalysts have included palladium-rhodium carbon, 
methyloxerhenium oxides, titanium, titanium dioxide surfaces, and zero-valent iron.  The first 
two catalysts are unlikely options for water treatment due to the harsh conditions required for the 
reactions.  These conditions include extremely low pH, three or less [42-44]. Titanium presents 
reaction rates similar to biological degradation; however, complete perchlorate reduction 
requires the presence of hydrogen, an explosive gas [45]. Finally, zero-valent iron, acting as both 
catalyst and electron donor, has been shown to treat perchlorate-contaminated waters, but the 
kinetics of the reaction are too slow for practical applications [46-48].   
 
 Several other chemical reduction methods have also been studied for the reduction of 
perchlorate. Electrochemical conversion is possible but currently not practical due to similar 
disadvantages including slow degradation kinetics. Several studies reviewed in Srinivasan and 
Sorial [27] have attempted to determine the mechanism and kinetics of perchlorate degradation. 
These studies have included the use of numerous electrodes including platinum, technetium, 
rhenium, ruthenium, tin, and rhodium. Some general problems identified in these experiments 
include competitive inhibition of perchlorate degradation from similar anions such as chloride 
and sulfate [47]. As noted in ion exchange, these anions are typically found in much greater 
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concentrations in drinking water than perchlorate. The degradation process was also found to be 
too slow for practical use in drinking water facilities [49].   
 
2.1.2.2. Biological Degradation – Biological degradation of perchlorate in laboratory, pilot scale 
and full-scale applications has been shown to successfully treat perchlorate [27].  The organisms 
responsible for perchlorate reduction were once thought to be a very limited group. However, 
perchlorate-reducing microbes have been found in a variety of environments and function very 
differently metabolically [50].   
 
 Nonetheless, trends have arisen out of perchlorate-reducing organism studies. For 
perchlorate reduction to occur, the bacteria require anoxic or anaerobic growth conditions.  The 
presence of oxygen inhibits the use of perchlorate as the terminal electron acceptor [50-52]. 
Nitrate can also have a competitive influence on some perchlorate-reducing organisms [50, 51]. 
The metabolism of perchlorate degradation and detailed analysis of the enzymes responsible for 
degradation are discussed in the following section.  
 
 Full-scale treatment of perchlorate has been demonstrated in several non-drinking water 
sites. One of the first examples of perchlorate microbial degradation was conducted in fluidized 
bed reactors in California and Texas [53].  The reactors were able to successfully treat 
perchlorate contamination of 0.5 to 1 mg/L down to a non-detectable level of less than 4 µg/L. 
 
 One example of naturally-occurring perchlorate degradation includes the Salton Sea in 
California [54]. The Colorado River has perchlorate levels up to 4 µg/L.  However, the Salton 
Sea, receiving Colorado River water, contains no detectable levels of perchlorate.  It is thought 
that the seabed, with low dissolved oxygen, is an optimal environment for naturally-occurring 
perchlorate degradation.  
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 While several examples for perchlorate degradation in engineered and natural systems 
exist, the technology has yet to be used in drinking water facilities for treatment of perchlorate 
contamination. This is mainly due to the public resistance or the aptly named “yuck” factor. The 
general public often takes issue with introducing bacteria to clean drinking water. Also, potential 
health effects could include elevated levels of chlorate or the toxic chlorite. Science has 
considerable work ahead to assure the public that the microbes present no adverse health 
implications.   
 
2.1.3 Current Treatment Technologies Summary: Current treatment of perchlorate relies on 
the separation or degradation of perchlorate.  Separation technologies, including granular 
activated carbon, membranes, and ion exchange, all suffer from similar drawbacks. The 
technologies are unable to target perchlorate specifically and require the disposal of concentrated 
waste. Adaptation of the current treatment technologies to target perchlorate specifically also has 
drawbacks. Modified GAC lacks perchlorate selectivity.  Ion exchange resins modified for 
perchlorate can be difficult to regenerate.  Perchlorate degradation technologies include chemical 
and biological degradation. Chemical degradation requires the use of heavy metal catalysts. The 
reaction kinetics for chemical perchlorate degradation are currently too slow for practical 
application in drinking water. Biological degradation requires an anaerobic environment due to 
competition with other preferential electron acceptors. Environmental conditions such as pH and 
temperature may need to be strictly controlled for optimal performance. 
 
2.2: ENZYMES RESPONSIBLE FOR PERCHLORATE DEGRADATION.  
 
The biological degradation of perchlorate is carried out through two enzymes, perchlorate 
reductase and chlorite dismutase (Figure 5). Perchlorate reductase catalyzes the reactions 
converting perchlorate into chlorate followed by conversion to chlorite.  Chlorite dismutase 
converts the toxic chlorite into chloride and oxygen. Each enzyme is discussed below while 
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noting the metabolically unique nature of the enzyme perchlorate reductase and the distinctive 
reaction carried out by chlorite dismutase.   
 
 For my research, the dissimilatory perchlorate-reducing organism, Azospira oryzae 
(synonym Dechlorosoma suillum) was used.  This bacterium is a gram-negative rod, a 
nonfermentative facultative anaerobe and a part of the β subclass of Proteobacteria. The 
organism is unable to form spores and is motile by a single polar flagellum. The cells are capable 
of growing on simple organic fatty acids and use O2, ClO3
-
, ClO4
-
, or NO3
-
 as electron acceptors.  
Perchlorate and chlorate are fully oxidized to chloride and nitrate to nitrogen gas [55].  
 
2.2.1 Perchlorate Reductase: Perchlorate reductases are metabolic enzymes allowing organisms 
to gain energy from the oxidation energy difference between electron donor and electron 
acceptor.  The enzymes are membrane associated and require an electron donor such as acetate, 
methyl viologen, or nicotinamide adenine dinucleotide. Perchlorate reductase is a periplasmic-
associated enzyme and a member of the type II dimethyl sulfoxide (DMSO) reductase family 
[56]. The enzyme can be divided into two categories.  The first class of enzyme is capable of 
catalyzing both reactions, perchlorate to chlorate and chlorate to chlorite. The second class is 
only able to catalyze the reaction of chlorate to chlorite. Despite these differences, the enzymes 
all contain a molybdenum cofactor known as bis(molybdopterin guanine dinucleotide)-
Figure 5: Enzymatic Conversion of Perchlorate.  
The enzymes responsible for the conversion of perchlorate into chloride are 
perchlorate reductase (Pcr) and chlorite dismutase (Cld).  Pcr transfers four 
electrons to the central chloride atom while releasing two water molecules. 
The final reaction, chlorite to chloride, involves an intramolecular exchange 
of four electrons between the oxygen and chloride atoms.  This results in the 
separation of the molecule into chloride and diatomic oxygen. 
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molybdenum [57]. Perchlorate reductase has been shown to be a heterodimer or trimer of α, β, 
and γ subunits [56].  The α subunit contains the molybdenum cofactor.  The β subunit contains an 
iron-sulfur cluster thought to be responsible for the electron transfer.  The γ subunit is a 
cytochrome b moiety and is not present in all forms of perchlorate reductase.  A final protein, δ, 
is thought to function as a chaperone protein in the formation of the α β heterodimer [56].  
 
 Purified perchlorate reductase from the strain GR-1, has been studied in the perchlorate 
reducing strain, GR-1[52]. This strain GR-1 was later determined to be Dechlorosoma suillum, a 
synonym of A. oryzae, through DNA hybridization [58]. This perchlorate reductase is a 
periplasmic enzyme. It has a molecular mass of 420 kDa and is comprised of a trimer of 
heterodimers (α3β3). In addition to containing molybdenum, the subunits contain selenium [52]. 
Perchlorate reductase from Dechloromonas aromatica RCB overexpression and purification was 
attempted [59]. However, the enzyme was never successfully overexpressed as a result of 
deficient rare codons. 
 
2.2.2 Chlorite Dismutase: This enzyme is responsible for the co-metabolic reduction of chlorite 
into chloride and oxygen. Accumulation of chlorite is toxic for organisms, and chlorite must be 
removed from the system when using perchlorate or chlorate as a terminal electron acceptor. 
Chlorite dismutase is a highly-conserved enzyme located in the periplasm of perchlorate-
reducing bacteria [60]. The enzyme is the only known protein, aside from photosystem II, 
capable of forming diatomic oxygen [56]. Both oxygen atoms of the diatomic oxygen are 
thought to come directly from chlorite dismutase [61].  
 
 Chlorite dismutase has been purified from Azospira oryzae and is a homotetramer of 32 
kDa subunits containing approximately one heme B (protoheme IX) per monomer [62]. The 
enzyme is very specific to chlorite, showing no enzymatic activity with hydrogen peroxide, 
perchlorate, chlorate, or nitrite [62]. Accumulation of chlorite in concentrations exceeding 225 
mM results in loss of Cld activity, with diminished activity occurring in chlorite concentrations 
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exceeding 20 mM [62]. Chlorite dismutase has been heterologously expressed from 
Dechloromonas aromatic RCB in Escherichia coli.  In these experiments, chlorite dismutase was 
shown to complete a limited number of reactions before suicidal inactivation.  Approximately 
1.7x10
4
 molecules of chlorite were degraded per active site [63].  
 
2.2.3 Preparation of Enzymes for Use in This Study: Since only one of the enzymes, chlorite 
dismutase, has been successfully overexpressed in E. coli, Azospira oryzae lysates were used as 
the source of Pcr and Cld as previously described [52]. For the purposes of this study, cell lysates 
refer to cell extracts obtained after sonication. Soluble protein fraction refers to the enzymes that 
are separated by ultra-centrifugation from lipids. 
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CHAPTER 3 - MATERIALS AND METHODS 
 
Preparation of OmpF Protein. To overexpress the Escherichia coli outer membrane protein, 
OmpF, the strain BL21(DE3) omp8 with the inserted hybrid plasmid pGEM-5Zf(+)-pET-3a, 
ompF (pGOmpF) was obtained from Dr. Meier’s Lab in Basel, Switzerland [64, 65].  Purified 
protein was obtained using a previously described method [66] as follows.  BL21(DE3) omp8 
pGOmpF freezer cultures were streaked onto Luria-Bertani Lennox (LB) plates with 50 mg/L 
ampicillin (Amp) and incubated for 18 hours at 37°C.  Individual colonies were immediately 
transferred. To assure retention of the plasmid, fresh plates directly streaked from -80°C were 
used.  Three colonies were transferred to three 5 mL starter cultures and incubated with aeration 
at 37°C until growth reached an optical density at 600 nm of 0.6 (approximately 18 hours). Two 
of the starter cultures with optimal growth were each transferred to 1 L LB Amp broth and 
grown to an OD600 of 0.6 (approximately 6 hours).  Cultures were induced with 0.4 mM 
Isopropyl β-D-thio-galactoside (IPTG) (Research Products International Corp., Mt. Prospect, IL) 
for six hours.  Following induction, cells were pelleted at 5000xg for 15 min and stored at -80°C 
for up to three months.   Prior to lysis, cells were thawed on ice and resuspended with 10 mL per 
gram wet cell weight of 20 mM Tris-Cl pH 8.0 with 1 U/mL DNase. (Roche Applied Science, 
Indianapolis, IN)  Cell membranes were disrupted using a sonic dismembrator (Fisher Scientific 
Model 500 with Branson Tip Model 101-148-062, Waltham, MA).  Three lysis cycles of five 
minutes alternating between a three second pulse at an amplitude of 35% and two seconds off, 
followed by five minutes on ice, were performed.  Upon addition of freshly prepared 20% (w/v) 
sodium dodecyl sulfate (SDS) stock solution to a final concentration of 2%, the cell lysis solution 
clarified. The disrupted peptidoglycan layer and the associated OmpF were pelleted at 40000 x g 
for one hour at 4°C using a Beckman ultracentrifuge (Beckman-Coulter, Fullerton, CA). The 
pellet was washed three times with 5 mL of 20 mM phosphate buffer at pH 7.4 to remove traces 
of SDS.  After washing, the lysate pellet was resuspended in 0.125% n-octyl-oligo-oxyethylene 
(octyl-POE) (Alexis Biochemicals, Farmingdale, NY) 20 mM phosphate buffer, pH7.4. The 
suspension was homogenized on ice using a manually operated Wheaton 7mL homogenizer 
followed by gentle stirring at 37°C for one hour, then centrifuged at 145,000 x g for 45 minutes 
at 4°C in a Beckman Ultracentrifuge.  The cell pellet was resuspended in 3% Octyl-POE, 20mM 
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phosphate buffer at pH 7.4 and homogenized and centrifuged as before. Upon completion of the 
final centrifugation, OmpF protein remained suspended in the supernatant. Wash supernatants 
and OmpF were run on a 12% SDS Page gel at 120 V [67].  Bicinchoninic acid (BCA) (Pierce, 
Rockford, IL) assays were performed to determine protein concentration. OmpF protein was 
stored in sterile 1.5 mL microcentrifuge tubes at 4°C for up to three months. 
 
Verify Azospira oryzae Identity. The identity of the Azospira oryzae ATCC number BAA-33 
was verified by sequencing the 16S ribosomal RNA gene.  DNA from the organism was 
extracted using the PowerSoil DNA Isolation Kit (Mo Bio, Carlsbad, CA).  The polymerase 
chain reaction (PCR) reagents were obtained from a Qiagen Taq PCR Master Mix Kit (Qiagen, 
Valencia, CA) using standard 27 forward primer (5′-6-FAM-AGA GTT TGA TCM TGG CTC 
AG-3′) and 926 reverse primer (5’-CCG TCA ATT CCT TTA AGT TT-3’. Cycle conditions 
included an initial 95°C run for 3 minutes.  This was followed by 30 cycles of 45 seconds at 
94°C, 1 minute at 59°C and 2 minutes at 72°C. A final extension period was included at 72°C for 
10 minutes. PCR product was purified using the QIAquick PCR Purification Kit (Qiagen, 
Valencia, CA). The sample was sequenced at the W.M. Keck Center for Comparative and 
Functional Genomics at the University of Illinois (Urbana, IL).  
 
Preparation of Azospira oryzae Soluble Protein Fraction. Azospira oryzae ATCC number 
BAA-33 was purchased from ATCC (ATCC, Manassas, VA).  Strains were stored in 30% 
glycerol stocks at -80°C. A. oryzae was grown using a previously published media [68] without 
the reductant and the hydrogen electron donor.  Sodium acetate tri-hydrate was added to a molar 
concentration of 14.8 mM.  Sodium perchlorate was added as an electron acceptor to a final 
concentration of 8.2 mM. A complete media list and order of preparation is included in 
Appendix A.  Anaerobic test tubes containing 100 mL of media were capped with rubber 
stoppers and crimp sealed.  The media was vacuumed three times with 80% nitrogen and 20% 
carbon dioxide mix for 10, 5 and 2 minutes with final pressure at 10 psi.  Media was autoclaved 
and inoculated from the 30% glycerol freezer stock. Cells were grown to an OD600 of 0.4.  
Cultures were distributed into 9 mL aliquots with 1 mL glycerol.  Culture stocks were stored at -
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80°C for up to three months.   Culture stocks were thawed at room temperature and transferred to 
a 2.5 L media prepared similarly in 5 L specialized anaerobic flasks (Chemglass, Vineland, NJ).  
Cells were grown to an OD600 of 0.6. Upon completion of growth, cells were harvested, pelleted 
and lysed in two different environments, anaerobic and aerobic.  Anaerobic preparation was 
performed under N2/H2 headspace (49:1 v/v) in a COY anoxic glove box and sealed centrifuge 
tubes while aerobic preparations were performed on an open bench top. Soluble protein fractions 
were prepared similarly as previously described [52].  Cells were pelleted at 6000 x g for 10 
minutes.  Cell pellets were resuspended in 2 mL per gram wet weight cells of 50 mM potassium 
phosphate buffer, pH 6.0 with 0.1 mg/L DNase.  After addition of the lysis buffer, cell 
membranes were disrupted using an amplitude of 35% on a sonic dismembrator (Fisher 
Scientific Model 500 with Branson Tip Model 101-148-062, Waltham, MA).  Three lysis cycles 
of five minutes alternating between a three second pulse at an amplitude of 35% and two seconds 
off, followed by five minutes on ice, were performed.  The cell extract was centrifuged at 5000 x 
g for 15 minutes at 4°C. 500 µL samples of the cell lysate supernatant were collected, treated 
with glycerol to a final concentration of 10% (v/v), and stored on ice for enzymatic analysis.  
The remaining cell lysate was centrifuged in a Beckman ultracentrifuge at 145,000 x g for one 
hour at 4°C to separate soluble protein from lipids.  The soluble protein fraction was collected 
and tested for enzyme activity using the Methyl Viologen (MV) assay detailed below and protein 
content using BCA.  
 
Perchlorate-Reducing Lysate Activity Assays using Methyl Viologen (MV). Enzymatic 
activity was analyzed using the electron shuttle MV, the electron donor sodium dithionite and the 
electron acceptor sodium perchlorate at room temperature (20°C) as previously described [52].  
The buffer was purged of oxygen with 100% N2 for thirty minutes.  Headspace oxygen was 
removed with 100% nitrogen for five minutes.  Reagents, sodium dithionite and perchlorate, 
were purged of oxygen for five minutes, and headspace oxygen was removed for one minute.  
For crude and purified lysates, 2 mL of assay mixture containing 0.5 mM of MV (Acros 
Organics, Pittsburgh, PA) in 50 mM Tris-Cl
-
, pH 7.5 was added to anaerobic cuvettes (Helma, 
Mülheim, Germany) with cap and septa. 20 µL of cell lysate or soluble protein fraction was 
added and the sample blanked at 578 nm in a spectrophotometer.  1-5 µL of 0.2 M sodium 
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dithionite (Alfa Aesar, Ward Hill, MA) was added to achieve an initial absorbance of 1.8-2.0 at 
578 nm.  The sample was allowed to sit for 2-5 minutes to consume oxygen, and measurements 
were taken at room temperature until a level absorbance profile was achieved.  20 µL of 100 mM 
sodium perchlorate monohydrate (Fisher Scientific, Pittsburgh, PA) was added.  The decreasing 
absorbance was measured until a zero value was achieved.  The slope of the decreasing 
absorbance was calculated to determine activity. A similar procedure was used for vesicles, 
prepared as described below, except 400 µL of vesicles was added to the assay mixture and 
allowed to sit 10 minutes to consume oxygen before the addition of perchlorate.  All samples 
were analyzed in a COY anoxic glove box to reduce oxygen exposure.   
 
Endpoint Assays using Nicotinamide Adenine Dinucleotide (NADH) and Phenazine 
Methosulfate (PMS).  To analyze endpoint concentrations of anions, a recently developed 
oxidation reduction reaction assay was used [69].  50mM morpholinepropane sulfonic acid 
(MOPS) pH7.0 was placed in anaerobic bottled. The buffer was purged of oxygen with 100% N2 
for 30 minutes. The bottles were capped with rubber stoppers and crimp sealed. Oxygen was 
removed from the headspace with 100% N2 for 5 minutes.  Buffer was autoclaved and stored in 
an anoxic glove box.  NADH and PMS were added to the buffer to a final concentration of 1 mM 
and 100 µM respectively to obtain the assay mixture.  Two mL of assay mixture were added to 
sealed vials along with 20 µL of cell lysates or soluble protein fraction. Perchlorate, nitrate, 
sulfate, and anion combinations were added at concentrations ranging from 100 to 500 µM.  
Reactions were allowed to proceed at room temperature for eight hours.  Samples were frozen at 
-20°C to halt enzyme activity.  Samples were filtered through a 0.22 µm syringe filter and 
analyzed as previously described [70] using capillary electrophoresis (CE). The system, 
Beckman Coulter P/ACE MDQ system (Beckman Coulter, Brea, CA), utilized a bare fused-silica 
capillary with an inner diameter of 75 µm and outer diameter of 375 µm.  Samples were 
analyzed using running buffers provided in the Beckman Coulter Anion Analysis Kit, run at 
20,000 volts with separation duration of ten minutes and detected using indirect UV detection set 
at 230 nm. Samples were also analyzed using ion chromatography on an Ion Pac AS-16 
Hydroxide Selective Anion Exchange Column and an Ion Pac AS-18 Hydroxide-Selective Anion 
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Exchange Column on a Dionex ICS-2000 system (Dionex, Sunnyvale, CA) using 65 mM KOH 
eluent and a 1.2 mL/min eluent flow rate as previously described [71, 72].   
 
Protease and Protease Inhibitor Treatment of Soluble Protein Fraction.  The enzymes’ 
susceptibility to the protease Proteinase K (Roche Applied Science, Indianapolis, IN) was 
analyzed. Cell lysates were prepared and treated with 5% (v/v) 20 mg/mL Proteinase K in double 
distilled water. The ratio of Proteinase K was adapted from RNA isolation [73]. The sample was 
incubated at room temperature for one hour.  Protein content and enzyme activity were analyzed 
using BCA and MV assay respectively.  Values were compared to negative control samples 
containing cell lysate and double distilled water. Protease inhibitors were also tested to determine 
their ability to limit the decline of perchlorate-reducing activity. The Complete Mini EDTA Free 
Protease Inhibitor Cocktail (Roche Applied Science, Indianapolis, IN) tablet was added to 10 mL 
of soluble protein fraction. Fractions were incubated at 4°C for 48 hours. Soluble protein fraction 
containing no protease inhibitor was incubated as a control.  
 
Vesicle Formation with OmpF Insertion and Soluble Protein Fraction Encapsulation in 
Lipids and Polymer. Vesicles were formed using the previously published method of film 
rehydration [18]. The symmetric poly-(2-methyloxazoline)-block-poly-(dimethylsiloxane)-
block-poly(2-methyloxazoline) (PMOXA15-PDMS110-PMOXA15) was a gift from the Meier lab 
at the University of Basel, Switzerland and synthesized as published [17, 18].  Twelve 
milligrams of the polymer was dissolved in a 100 mL round bottom flask with 2 mL of 
chloroform.  The chloroform was slowly removed using a Wheaton Rotary Vacuum Evaporator 
at room temperature under 100 mbar vacuum. Films were further dried under high vacuum of 5 
mbar for 4 hours. Twenty milligrams of lipid with a 9:1 ratio of soy asolectin and cholesterol 
(Sigma-Aldrich, St. Louis, MO) were treated similarly to obtain a lipid single layer film.  Two 
mL of soluble protein fraction and varying molar concentrations of purified OmpF were added to 
the round-bottom flask.  The solution was mixed by alternating 30 second bath sonication and 
vortexing for 5 minutes.  The mixture was stirred while stored at 4°C for 12 hours, sonicated and 
vortexed for an additional 5 minutes, and stirred while stored at 4°C for an additional 24 hours.  
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This treatment results in a cloudy, red mix that was then extruded through a 1 µm track-etched 
filter (Nucleopore, Whatman, GE Healthcare, Piscataway, NJ) in a LIPEX extruder (Northern 
Lipids, Burnaby, British Columbia, Canada).  The solution was extruded an additional ten times 
through a 0.4 µm track-etched filter. To break up protein aggregates, the extruded unilamellar 
vesicles were treated with 5% (v/v) of 20 mg/mL Proteinase K for one hour at room temperature.  
To separate non-inserted OmpF, non-encapsulated protein and vesicles, size exclusion 
chromatography with a Sephacryl 500-HR column (GE Life Sciences, Piscataway, NJ) on a 
ÄKTAprime plus system (GE Life Sciences, Piscataway, NJ) was used with a maximum column 
pressure of 0.38 mPa and a flow rate of 0.5 ml/min [66].  Activity of encapsulated soluble 
protein fraction was measured with the MV assay and a vesicle volume of 400 µL.  The vesicles 
size (diameter) and uniformity (polydispersivity index – PDI) were analyzed using dynamic light 
scattering (DLS) on a Zetasizer Nano ZS90 (Malvern Instruments Ltd., Malvern, UK) using a 
632.8 nm He-Ne gas laser at 12.8° and 90°.  Samples were analyzed using a refractive index of 
1.47, absorption value of 0.10 and at room temperature.  Reported values are an average 
measurement of three readings of the same sample.  
 
Transmission Electron Microscopy (TEM). Transmission Electron Microscopy (TEM) was 
used to confirm formation of vesicles using a JEM-2100F TEM with LaB6 emitter (JEOL USA, 
Inc., Peabody, MA) located at the University of Illinois Material Research Laboratories (Urbana, 
Il.) Ultrathin holey carbon grids supported on gold mesh (Ted Pella, Inc., Redding, CA) were 
prepared for vesicle application by charging for 45 seconds under a Denton DPG-1 glow-
discharge system (Denton Vacuum Inc., Moorestown, NJ) at 200 mA. Vesicle dilutions of 1:2 by 
volume in 50 mM phosphate buffer at pH 6.0 were used. Diluted vesicles were then incubated on 
the charged carbon grids for 2 minutes and then blotted. Grids were stained with 1% uranyl 
acetate dye (SPI, West Chester, PA) and immediately blotted. Grids were stained a final time for 
1 minute and blotted. They were allowed to air-dry for five minutes. Grids were viewed at 200 
kV and 110 µA e-beam current, and several images were acquired per grid at approximately 50k 
to 200k times magnification.  
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Permeability of Vesicles. Stopped-flow spectroscopy on a SX.17 MV spectrometer (Applied 
Photophysics, Surrey, UK) was used to determine permeability through the OmpF [74]. Prepared 
vesicles in 50 mM phosphate buffer at pH 6.0 were introduced to an equal volume of 
hyperosmotic solution of 1 molar sucrose or sodium chloride. The resulting shrinkage resulted in 
a change in the scattering of light that was measured and characterized as k.  Dilutions of 
vesicles were tested 5-10 times. Tests were conducted at 10°C and 600 nm wavelength light. 
Light-scattering output for each test was averaged, normalized, and used with the following 
Equation 1 [74] to calculate vesicle permeability:  
 
                         
 
Equation 1: Permeability Equation.  
Stopped flow analysis is used to calculate permeability using the above equation where Pf = 
permeability; k = initial rise or fall of light scattering fitted to an exponential rise equation; S/Vo 
= specific surface area of vesicles, where S is initial vesicle surface area and Vo is initial vesicle 
volume; Vw = molar volume of water, and Δosm = osmolarity gradient across the vesicle 
membrane. For sucrose, the Δosm was 1.0878 for a 1 molar solution [75].  
 
OmpF Diffusive Transport and Vesicle Leakage Experiments in Lipids. Lipid films were 
produced as described in a previous section with 10 mg of lipids (7.108 mg of 1-palmitoyl-2-
oleoyl-sn-glycero-3-phophocoline (POPC), 1.44 mg of 1-palmitoyl,2,oleoyl-sn-glycero-3-
phophoethanolamine (POPE), and 1.45 mg 1,2-dioleoyl-sn-glycero-3-phosphate (DOPA) 
(Avanti Polar Lipids, Inc., Alabaster, Alabama) but were hydrated with 2 mL phosphate buffered 
saline (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4·7H2O, 1.4 mM KH2PO4)  with 2 mM 
carboxyfluorescein (Life Technologies, Invitrogen, Carlsbad, CA) and 50:1 (w/w) OmpF.  After 
size exclusion chromatography, sample fluorescence was measured on a SpectraMax Gemini 
(Molecular Devices, Sunnyvale, CA). Values were compared to a negative control sample 
without OmpF.   
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CHAPTER 4 - RESULTS 
 
 My work focused on the production of synthetic cells comprised of human-made and 
cellular components from two organisms: the artificially constructed ABA membrane polymer 
along with Escherichia coli and Azospira oryzae proteins. The purpose of these experiments was 
to determine the ability of these vesicles to reduce perchlorate. The Results chapter is divided 
into four sections: Perchlorate-Reducing Enzyme Production and Stability, Analytical 
Measurements of Anion Concentrations, Production of OmpF, and Formation and Analysis of 
Lipid and Polymer Vesicles. Understanding the stability of the enzymes under varying 
conditions is an important step in evaluating the potential use of these nano-vesicles for the 
reduction of perchlorate-contaminated drinking water, and the enzymes’ ability to degrade 
perchlorate in the presence of competing anions would result in a dramatic improvement in 
perchlorate drinking water treatment. Maintaining activity would reduce the cost associated with 
operation. Finally optimizing OmpF overexpression and insertion ratios in polymer vesicles 
would allow for optimal diffusion of perchlorate into the vesicle for degradation.  
 
4.1: PERCHLORATE-REDUCING ENZYME PRODUCTION AND STABILITY. 
 
4.1.1 Confirmation of Azospira oryzae Culture: The perchlorate-reducing bacteria was verified 
by sequencing the 16S rRNA gene (Figure 6). Its identity as Azospira oryzae was confirmed by 
comparing sequences in the Ribosomal Database Project. 
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Figure 6: 16S rRNA Sequence. 
The 5’ to 3’ ribosomal gene was amplified using polymerase chain reaction and sequenced. The 
sequence match score was 1.00. 
 
4.1.2 Perchlorate-Reducing Enzyme Production: To obtain the perchlorate-degrading 
enzymes, perchlorate reductase and chlorite dismutase, growth of Azospira oryzae was 
performed as described [51].  Initially the organism grew well as determined by a previous 
graduate student [64]; however, during the transition to my work, the growth slowed 
considerably, with the organism taking up to 25 days to reach stationary phase.  A new media 
(described in the Materials and Methods) was used and optical density was measured at 600nm 
to determine cell growth (Figure 7).  The organism reached stationary growth around one day 
after inoculation. This allowed for large volumes of cells to be produced quickly, and the cells 
contained equivalent enzymatic activities as the previously published method (data not shown).  
 
 
1 TCGAACGGCAGCACGGGAGCTTGCTCCTGGTGGCGAGTGGCGAACGGGTG 
51 AGTAATACATCGGAACGTACCCAGGAGTGGGGGATAACGTAGCGAAAGTT 
101 ACGCTAATACCGCATATTCTGTGAGCAGGAAAGCGGGGGATCGCAAGACC 
151 TCGCGCTCTTGGAGCGGCCGATGTCGGATTAGCTAGTTGGTGAGGTAAAA 
201 GCTCACCAAGGCGACGATCCGTAGCAGGTCTGAGAGGATGATCTGCCACA 
251 CTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAAT 
301 TTTGGACAATGGGGGCAACCCTGATCCAGCCATGCCGCGTGAGTGAAGAA 
351 GGCCTTCGGGTTGTAAAGCTCTTTCGGCGGGGAAGAAATGGCAACGGCTA 
401 ATATCCGTTGTTGATGACGGTACCCGCATAAGAAGCACCGGCTAACTACG 
451 TGCCAGCAGCCGCGGTAATACGTAGGGTGCGAGCGTTAATCGGAATTACT 
501 GGGCGTAAAGCGTGCGCAGGCGGTTTCGTAAGACAGACGTGAAATCCCCG 
551 GGCTCAACCTGGGAACTGCGTTTGTGACTGCGAGGCTAGAGTACGGCAGA 
601 GGGGGGTAGAATTCCACGTGTAGCA 
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Figure 7: Growth of Azospira.  
The sterile control was uninoculated media. Spectrophotometric measurements were taken at 600 
nm.  Experiments were performed with biological triplicates with negligible deviation. Error bars 
represent standard deviation. 
 
To assure that cell growth corresponded to perchlorate reduction, time points were 
analyzed for perchlorate, chloride and acetate (Figure 8). Samples were taken starting at 0 hours; 
however, only samples starting at 23 hours have been analyzed. Chloride increases 
corresponding with growth of Azospira oryzae and conversion of perchlorate into chloride. 
Perchlorate and acetate decrease. Negative controls have only been performed once. The slight 
increase observed at early time points could correspond to measurement or dilution error. 
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Figure 8: Dissimilatory Perchlorate Reduction. 
Chloride, perchlorate and acetate were monitored. Dissimilatory perchlorate reduction and 
acetate consumption corresponded with cell growth as in Figure 7 and an increase in chloride 
concentration.  Negative control was sterile growth media. Experiments except sterile controls 
were performed with biological triplicates. Capillary analysis was performed once on each 
sample. Error bars represent standard deviation. 
 
 Initially, ion chromatography was used to determine the perchlorate, nitrate and sulfate 
concentrations.  This was met with a number of difficulties both my fault and hardware 
malfunction. In Figure 9, ion chromatograms are shown. In panel a, the chromatogram had a 
large peak at approximately 3.5 minutes corresponding to chloride concentration.  It was later 
determined that this was due to adjustment of the buffer pH value using hydrochloric acid. In 
panel b, the chromatogram was noisy and contained no data of value.  It was later determined 
that the influent tube on the column had a small leak. The leak was repaired; however in the 
meantime, I had switched to capillary electrophoresis, so all subsequent analyses were performed 
using the CE technique.   
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Figure 9: Ion Chromatography Analysis of Perchlorate. 
a) Representative ion chromatogram of 100 µM perchlorate with no soluble protein fraction. The 
buffer used for ion chromatography analysis had pH adjusted with hydrochloric acid, resulting in 
a large chloride peak at approximately 3.5 minutes. b) Ion chromatogram with 100 µM of 
perchlorate in properly prepared buffer. The results are noisy with no discernible peak 
corresponding to perchlorate concentration. It was later determined that the influent tube on the 
column was leaking.  
 
a 
b 
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4.1.3 Enzyme Characteristics: Once perchlorate reduction was verified, the soluble protein 
fraction containing perchlorate-reducing enzymes, perchlorate reductase (Pcr) and chlorite 
dismutase (Cld), partially purified as described in the Materials and Methods section. The 
enzymes’ functionality was then assessed under various conditions. These included aerobic 
versus anaerobic preparations, exposure to glycerol, and the introduction of protease and 
protease inhibitors.  The enzymatic activities in this section were determined using the MV assay 
and 20 µL of cell lysate. Figure 10 shows a typical MV assay.  
 
Figure 10: Typical Methyl Viologen Assay.  
The background activity was analyzed from time 0-60 seconds.  During this time, the methyl 
viologen scavenged oxygen from the reaction mixture. Lysate activity or soluble protein fraction, 
analyzed from 70-150 seconds, measured the intrinsic reducing power of the cell lysate. 
Perchlorate Reducing Activity, time 170-200 was measured upon addition of perchlorate. Large 
spikes and drops in the absorbance resulted from opening the spectrophotometer to add cell 
lysate or perchlorate. 
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 For each test, the slope of the perchlorate-reducing activity was determined based on the 
oxidation of methyl viologen. Enzymatic activity was calculated from the slope and Equation 2 
[76].  
         (
 
 
)  
  
      
      
      
Equation 2: Enzyme Activity. 
The activity of the extract is defined as 1 µmole of reduced methyl viologen oxidized per minute, 
per liter of extract. The change in the slope of the absorbance with respect to minutes (AU/min), 
the total volume (TV) in µL, the µmolar absorptivity of methyl viologen (ε) with a value of 13.1 
L/(mMol*cm) as previously determine [77], the path length (b) in centimeters, and the sample 
volume (SV) in µL were used to determine activity. 
 
 Enzymatic activities varied with respect to level of purification. Cell lysate preparations 
were in the range of 40,000 to 50,000 U/L. Activities for soluble protein fraction resulted in 
values in the range of 20,000 to 25,000 U/L. See Appendix B for a table summarizing the 
activities of individual tests. Using Equation 2 and the colorimetric MV assay, several 
environmental conditions were tested to study the enzymatic stability of Pcr and Cld. 
 
4.1.4 Aerobic versus Anaerobic Lysate Preparation: Several studies offer conflicting results 
on oxygen sensitivity for the perchlorate-reducing enzymes. Aerobic storage of enzymes was 
reported to deteriorate activity of the enzymes with a half-life of two to three days in the 
Azospira oryzae GR-1 strain [52]. Other research showed a decrease in activity occurs in both 
aerobic and anaerobic conditions for enzymes from the organism Dechloromonas aromatica. 
[59].  To test whether aerobic preparation of the enzymes Pcr and Cld from A. oryzae was 
affecting activity in my experiments, I prepared cells lysates aerobically and anaerobically as 
described in the Materials and Methods section and compared the activity of each preparation. 
As shown in Figure 11, the enzyme activities were not significantly affected by the presence of 
oxygen (n=3 and P=0.439). Based on these results and the difficulty of anaerobic work, 
hydration, extrusion and exclusion of the perchlorate reducing vesicles was performed 
aerobically for all subsequent experiments. 
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Figure 11: Anaerobic and Aerobic Cell Lysate.  
The activity levels of cell lysate prepared anaerobically and aerobically show no statistically 
significant difference. Experiment was performed with biological triplicates and measurements 
in duplicate. Error bars are standard deviation.  
 
4.1.5 Glycerol Stabilization of Enzymes:  Adding glycerol to lysate has been shown to stabilize 
enzymes [51]. However, other sources report discrepancies with the benefits of glycerol addition 
[59]. The disagreement among the literature could be the result of using different strains of 
perchlorate reducers. As a result, it was important to test the benefits of glycerol on soluble 
protein fractions from A. oryzae.  Addition of 10% glycerol did not affect the initial activity of 
the enzymes (n=3 P=0.388, Figure 12a) and slowed the half-life deterioration of the enzymes 
(n=3 P=0.000005, Figure 12b). 
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Figure 12: Effects of Glycerol on Activity.  
a) Initial introduction of the glycerol does not affect the enzymatic activity. The activity of 
soluble protein fraction was determined using the MV assay and 20 µL of soluble protein 
fraction.  Glycerol activity was adjusted for dilution.  b) Lysate Glycerol sample was incubated 
with 10% glycerol at 4
○
C for 48 hours. Addition of glycerol, while not preventing all the 
deterioration of enzyme activity, significantly reduced the loss of activity. Experiments were 
performed with biological triplicates with duplicate measurements. Results are not statistically 
different. Experiments were performed with biological triplicates with duplicate measurements. 
Results are statistically different with error bars representing standard deviation.  
  
a
b
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4.1.6 Native Protease Degradation of Enzymes Pcr and Cld: To assess whether the loss of 
soluble protein fraction activity over time was the result of native proteases, soluble protein 
fractions were treated with a broad spectrum protease inhibitor, the Roche Applied Science 
Complete Mini Protease Inhibitor Cocktail (Figure 13). However, lysates treated with protease 
inhibitor showed reduced activity. This was unexpected but could be the result of the inhibition 
of a native protease responsible for protecting the perchlorate-reducing enzymes. 
 
Figure 13: Native Protease Degradation of Soluble Protein Fraction.  
Protease inhibitors were included in soluble protein fraction in order to prevent the decline of 
enzymatic activity.  Activities for the enzymes are shown after addition of protease inhibitor and 
incubated for 48 hours at 4
○
C. Protease inhibitor was added directly to the soluble protein 
fraction at 10 mg per 1 mL respectively.  Assay results were determined using 20uL of soluble 
protein fraction with reduced enzymatic activity due to extended storage.  Experiments were 
performed with biological duplicates with single measurements. Error bars represent standard 
deviation. 
 
4.1.7 Simulated Microbial Degradation: To simulate microbial degradation, the soluble protein 
fraction was treated with the protease, Proteinase K.  This simulated microbial degradation was 
also used later to test the protective abilities of the lipid and polymer vesicles. The initial 
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activities in this experiment were reduced because of extended storage. Treatment with proteases 
for one hour at 25
○
C resulted in significantly reduced activity (n=3 P=0.021, Figure 14). 
However, substantial activity remained in the treated cell lysate. This could be the result of 
adaptation of the cytoplasmic RNA preparation protocol. While the ratio of Proteinase K to 
soluble protein fraction is similar to the protocol, the concentration of the Proteinase K and 
soluble protein fraction is higher. In addition, the cited protocol calls for Proteinase K treatment 
of fifteen minutes at 37
○
C whereas my experiments were conducted for one hour at 25
○
C.  
 
 
Figure 14: Protease K Reduces Enzyme Activity. 
The above figure demonstrates the enzymes’ susceptibility to Proteinase K.  The protease was 
used to simulate microbial degradation.  Protease was added to the soluble protein fraction at 5% 
v/v with the control, Lysate, only having 5% v/v double distilled water. Assay activity was 
determined using 20 µL of soluble protein fraction. Experiments were performed in triplicate 
with duplicate measurements. Results are statistically different with error bars representing 
standard deviation.   
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4.2: ANALYTICAL MEASUREMENT OF THE SOLUBLE PROTEIN FRACTION’S 
ABILITY TO REDUCE ANIONS. 
 
 The following section focuses on the analytical measurement of the conversion of 
perchlorate to chloride. The purpose of these experiments is to assure complete conversion of 
perchlorate to chloride, as the formation of chlorite is toxic. As mentioned in the introduction, 
perchlorate treatment technologies are often hindered by the presence of similar anions which are 
often in greater concentrations than perchlorate. Data on the enzymes’ activity toward other 
anions are presented. Soluble protein fractions were incubated with varying concentrations of 
anions using the NADH assays as described in the Material and Methods Section. The NADH 
assay was published by another lab [69] during this thesis and proved to be more consistent than 
the methyl viologen assay in the presence of oxygen. For this reason, the NADH assay was used 
for anion competition analysis.  
 
4.2.1 Stoichiometric Conversion of Perchlorate to the Chloride Anion: To test that one mole 
of perchlorate was converted to one mole of chloride, varying concentrations of perchlorate were 
incubated with the soluble protein fraction in the presence of excess or limiting NADH 
concentrations.  Electrons donated to the reduction of perchlorate into chlorate and chlorate to 
chlorite can be directly measured using spectrophotometric methods utilized by the MV and 
NADH assays. Conversion of chlorite required no external electron donor.  Chlorite conversion 
was indirectly measured through the formation of diatomic oxygen, which is capable of 
accepting electrons from MV and NADH. Endpoint assays were performed to assure complete 
conversion of perchlorate to chloride.  
 
In Figure 15, varying concentrations of perchlorate were converted to chloride in near 1:1 
molar ratio.  Assay results showed no intermediate formation of chlorate or chlorite.  These 
results extended to reactions with limited NADH concentrations. Perchlorate incubated with the 
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minimum NADH requirement to convert perchlorate to chlorite resulted in near complete 
conversion of perchlorate to chloride with no intermediate chlorate or chlorite present.   
 
Figure 15: Stoichiometric Conversion of Perchlorate to Chloride. 
The conversion of perchlorate resulted in a near one to one molar conversion.  Three experiments 
were conducted.  The first and second include 100 µM and 400 µM of perchlorate with and 
without soluble protein fraction containing perchlorate-reducing enzymes and excess NADH.  
The third contains 500 µM perchlorate and enough NADH to convert perchlorate to chlorite. 
This indicates the both the perchlorate-reducing enzymes, Pcr and Cld, were functional 
converting perchlorate to chloride.  Assays were performed with 20 µL of soluble protein 
fraction. Assays were performed with one biological sample. 
 
  
100 µM 
400 µM 
500 µM 
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4.2.2 Reduction of Similar Anions by Pcr and Cld: In addition to studying the reducing ability 
of the A. oryzae enzymes for perchlorate, sulfate and nitrate were analyzed (Figure 16). For 
many of the current perchlorate-treatment technologies, similar anions such as nitrate and sulfate 
present inhibitory effects. Reduction of the anions was coupled to NADH as the electron donor. 
The soluble protein fraction was capable of reducing nitrate as previously published for A. 
oryzae [52]. The results did not show the formation of another anion such as nitrite. Nitrate was 
converted to an unknown compound; however, from previous research, nitrate is likely converted 
to nitrogen [51]. Sulfate was not reduced. An increase in sulfate concentration occurs because of 
the addition of the sulfate-containing soluble protein fraction. 
 
Figure 16: Soluble Protein Fraction’s Ability to Reduce Similar Anions.  
This figure demonstrates the ability of the soluble protein fraction to reduce nitrate.    Anions 
were added at a concentration of 100 µM with 20 µL of soluble protein fraction. Residual 
concentrations of nitrate could suggest that the process requires more than 5:1 molar ratio of 
NADH or the soluble protein fraction was unable to degrade minimal nitrate concentration. 
Sulfate was not reduced. An increase in sulfate concentration with the addition of soluble protein 
fraction is due to the sulfate concentration in the enzymes. Assays were performed with one 
biological sample.  
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4.2.3 Competitive Reduction of Similar Anions: Knowing that the enzymes had activity with 
nitrate, anion mixtures were incubated with the soluble protein fraction to determine if sulfate 
and nitrate had inhibitory effects on perchlorate degradation. Sulfate had no inhibitory effect on 
perchlorate end-point degradation and was not degraded by the enzymes (Figure 17). Apparent 
sulfate decreases in the 100 µM and the 400 µM are thought to be part of a matrix effect as 
sulfate and perchlorate elute at the same time. Samples were analyzed using NADH as electron 
donor with 20 µL of soluble protein fraction. 
 
 
Figure 17: Competitive Anion Reduction in the Presence of Sulfate.  
Sulfate did not inhibit the reduction of perchlorate nor was it reduced by the perchlorate reducing 
enzymes.  No chlorate or chlorite peaks were observed in capillary electrophoresis analysis. All 
sets include 500 µM NADH.  The first two sets of bars include 100 µM of perchlorate and 
sulfate with or without soluble protein fraction containing perchlorate-reducing enzymes.  The 
last two sets of bars include 400 µM of perchlorate and sulfate with or without enzymes. 
Reaction assays were incubated with the indicated concentration of each anion and 20 µL of 
soluble protein fraction. The small decrease in sulfate from No Enzyme to Enzyme in 100 µM 
and the larger decrease in 400 µM are thought to be matrix effects associated with sulfate and 
perchlorate eluting at similar times. Assays were performed with one biological sample.  
 
400 µM 
100 µM 
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Nitrate was competitively reduced with perchlorate; however, the enzymes’ affinity for 
perchlorate was much higher (Figure 18). This is consistent with the perchlorate-reducing 
organism of GR-1. The strain’s washed cell suspension when grown on perchlorate was unable 
to grow on nitrate [52]. At 100 µM concentrations of perchlorate and nitrate, the anions were 
reduced to very low concentrations. However, at 400 µM concentrations of the anions and 
limiting NADH concentration, perchlorate and nitrate were reduced by 84% and 15% 
respectively. However, despite the competitive effects of nitrate, the formation of chlorate or 
chlorite was not detected on the capillary electrophoresis.  
 
 
Figure 18: Competitive Anion Reduction in the Presence of Nitrate.  
Nitrate is shown to compete for electron donor, NADH. However, enzymes show greater affinity 
for perchlorate. All sets include 500 µM NADH.  The first two sets of bars include 100 µM of 
perchlorate and nitrate with or without enzymes.  The last two sets of bars include 400 µM of 
perchlorate and nitrate with or without enzymes. Reaction assays were incubated with the 
indicated concentration of each anion and 20 µL of soluble protein fraction. Assays were 
performed with one biological sample. 
  
100 µM 
400 µM 
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4.3: PRODUCTION OF OmpF.  
Study of the perchlorate-reducing enzymes pertains to one of the biologically important 
components of the perchlorate-reducing vesicles.  The following sections are devoted to the 
development of the other biologically important component, the OmpF pore. OmpF, a diffusive 
porin, was purified for insertion into the synthetic cell. OmpF purification was conducted on the 
E.coli double mutant (ΔompA ΔompC) with an OmpF IPTG-inducible-overexpression vector 
[65].  Purification of OmpF relies on manipulation of the solubility of the OmpF associated 
peptidoglycan layer.  SDS was used in elevated concentrations to insolubilize the peptidoglycan 
layer.  The SDS had the additional benefit of solubilizing most non-membrane associated 
proteins. After separating the OmpF from other cellular proteins, OmpF was resolubilized using 
the detergent Octyl-POE.  A final high-speed centrifugation resulted in the pelleting of the 
peptidoglycan layer. The soluble OmpF remained in the supernatant.  
 
 Some initial difficulties resulted from the induction of E. coli cells.  This was resolved by 
using freshly prepared IPTG.  Another problem occurred in the sonication of the cell pellet to 
disrupt the membranes.  It is important to note the model number of the probe used in sonication 
here as it results in up to four times stronger disruption than a standard probe.  Difference in 
probes resulted in a threefold difference in final OmpF concentration.  
 
 Purification of OmpF resulted in the monomer unit of OmpF upon heating, corresponding 
closely with the 37kDa published size of OmpF [65] (Figure 19). Note the dilutions decrease 
from Spin 1, Spin 2 and OmpF.  Spin 1 was diluted with larger volumes of buffer. However, 
bands on the gel are very dark signifying a large amount of protein. Spin 2 also has a significant 
amount of protein in each band. This corresponds to a significant loss of OmpF with each spin 
despite the use of the insoluble nature of the OmpF-containing peptidoglycan layer.   
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Figure 19: OmpF Purification.  
The following samples were run on a 12% SDS-Page gel.  Ratios indicated dilution factors for 
the same OmpF preparation.  Spin 1 (lanes 2-4) and Spin 2 (lanes 5-7) indicate solubilized 
fractions of cell lysates after each centrifugation and were not heat treated. Lanes 8, 9 and 10 
included the purified OmpF treated at 95°C for five minutes.   
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4.4: FORMATION AND ANALYSIS OF LIPID AND POLYMER VESICLES.  
 Having completed sections 1 through 3, the final step was to combine the biological 
components I had produced with lipids and synthetic polymer to form perchlorate-reducing 
vesicles. I also tested the vesicles’ ability to protect the enzymes from protease degradation.   
 
4.4.1 Perchlorate-Reducing Lipid Vesicles: Lipids were initially used to test the hypothesis 
that synthetic vesicles were capable of perchlorate degradation. Soy asolectin and cholesterol 
lipids were used to form vesicles with encapsulated Pcr and Cld as described in Materials and 
Methods. Two types of vesicles were prepared: with and without OmpF. The size and size 
distribution of lipid vesicles was assessed using dynamic light scattering (Figure 20). OmpF 
vesicles were slightly larger than No OmpF vesicles but not statistically different (n=3 P=0.254). 
The size distribution was determined from the polydispersivity index (PDI). For the purposes of 
this study, PDI values less than 0.15 were considered to represent uniform size. For lipid 
vesicles, the PDI for both OmpF and No OmpF vesicles were larger than 0.15. This was likely 
due to only extruding to a size of 400 nm. This step did not force all lipid vesicles into a uniform 
size. The purpose of extruding at 400 nm was to eliminate any large material. Extrusion down to 
200 nm was not performed to avoid vesicle lysis and the loss of perchlorate reducing enzymes. 
The PDI for the two sets is significantly different (n=3 P=.018). This may be due to the presence 
of the detergent Octyl-POE in the OmpF vesicles.  
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Figure 20: Size and Size Distribution of Lipid Vesicles.  
The diameter and polydispersivity index (PDI) for the vesicles were recorded using dynamic 
light scattering (DLS).  Values for size are given as average diameters. OmpF vesicles were 
slightly larger on average than No OmpF vesicles but not statistically different. The PDI, 
however, is significantly different for the two sets. The size distribution of OmpF vesicles was 
not as uniform as No OmpF vesicles. Error bars represent standard deviation.  
  
 
 Once the size of the vesicles was determined, the leakage of the vesicles was studied 
using the dye, carboxyfluorescein, to confirm incorporation and activity of OmpF. Vesicles were 
rehydrated with carboxyfluorescein and prepared as described. Once size exclusion of the 
vesicles was complete, fluorescence of the vesicles was measured (Figure 21). Vesicles without 
OmpF should be able to retain the carboxyfluorescein as there are no pores for the dye to diffuse 
through. No OmpF vesicles do show slightly elevated levels of fluorescence compared to OmpF 
vesicles. However, this difference is much smaller than values obtained in a similar experiment 
using polymer vesicles [64]. From the data, lipid vesicles were permeable to carboxyfluorescein. 
Carboxyfluorescein, with a molecular weight of 376.32 gram/mole, is a larger molecule than 
perchlorate which has a gram formula mass of 99.5 gram/mole.  The observed permeability of 
45 
 
carboxyfluorescein suggests that perchlorate, a smaller molecule, can diffuse in or out of vesicles 
with and without OmpF. 
 
 
 
Figure 21: Retention of Fluorescence In Lipid Vesicles.  
No OmpF vesicles show slightly higher fluorescence than OmpF Vesicles. Error bars represent 
standard deviation of six technical replicates.  
 
After characterizing the lipid vesicles, the perchlorate-reducing activity was determined 
using the methyl viologen assay and 400 µL of vesicle preparation (Figure 22). All of the 
experiments showed significantly reduced activities compared to soluble protein fraction assay 
values. As detailed in the Discussion, this is likely due to the limited perchlorate-reducing 
volume created in the vesicles. Background activity was observed in the no perchlorate OmpF, 
control. This is due to minute traces of oxygen and the innate reducing power of the soluble 
protein fraction. However, most important was that OmpF vesicles showed statistically 
significant elevated activity over No OmpF vesicles (n=3 P=.012). OmpF vesicles were also 
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exposed to Proteinase K for one hour and 25°C to determine the lipid’s ability to protect the 
enzymes inside the vesicles. OmpF vesicles with and without protease showed similar levels of 
activity (n=3 P=0.218). 
 
 
Figure 22: Perchlorate-Reducing Lipid Vesicles.  
Perchlorate reduction was observed in the lipid vesicles.  OmpF vesicles were capable of 
degrading more perchlorate than No OmpF and OmpF Control Vesicles. OmpF Protease vesicles 
maintain their ability to degrade perchlorate in the presence of protease. Methyl viologen assays 
were performed on biological triplicates. Error bars represent standard deviation. 
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4.4.2 Perchlorate-Reducing Polymer Vesicles: Lipid vesicles were used for proof of concept as 
the polymer material was in short supply but interpretation was complicated by their high 
permeability to carboxyfluorescein. Once the lipid vesicles were shown to reduce perchlorate, 
ABA polymer was used to create vesicles. An additional control, vesicles without OmpF but 
with detergent, was included. The detergent was hypothesized to aid in the insertion of A. oryzae 
native porins that could increase transport and thus perchlorate-reducing activity. Three different 
types of vesicles were prepared: 1) OmpF vesicles with the detergent Octyl-POE, 2) No OmpF 
vesicles with the detergent, and 3) No OmpF without detergent. The polymer vesicles were 
analyzed for their size and size distribution using dynamic light scattering. As shown in Figure 
23, the sizes and PDIs for polymer vesicles were much smaller than lipid vesicles despite similar 
preparation methods. OmpF and No OmpF polymer vesicles formed similar sized vesicles (n=3 
P=0.239) with similar polydispersivity indices (n=3 P=0.372). The PDI for the vesicles were 
within acceptable limits signifying that vesicles were uniform in size. However, the No OmpF 
No Detergent vesicles had an average size and PDI significantly larger than OmpF vesicles (n=3 
P=0.0025 P=0.0195), and the PDI of the No OmpF, No Detergent vesicle were slightly higher 
than the cut off range for acceptable uniform distribution.  
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Figure 23: Size and Size Distribution of Polymer Vesicles. 
The diameter and polydispersivity index (PDI) for the vesicles were recorded using dynamic 
light scattering (DLS).  Vesicles containing OmpF and Detergent had a diameter and PDI that 
were not statistically different than No OmpF Vesicles. However, diameter and PDI between 
OmpF and No OmpF, No Detergent Vesicles was statistically different. Error bars represent 
standard deviation.  
 
 To visually determine the size and distribution of the polymer vesicles, transmission 
electron microscopy was used to take images of the vesicles. In Figure 24, images for OmpF, No 
OmpF, and No OmpF, No Detergent vesicles are shown. OmpF and No OmpF vesicles are 
spherical and similar in size. The diameters of the vesicles on TEM are approximately 50 nm. 
This is smaller than data from DLS measurements. TEM images are thought to reduce the size of 
vesicles due to the drying involved in sample preparation [18]. Also, the distribution of sizes of 
the vesicles appears to range from 20 to 50 nm. No OmpF, No Detergent form interesting 
polymer shapes known as worms. A plausible explanation for the formation of worms is the lack 
of detergent.  For the purposes of the experiments, the formation of worms could result in a 
lower surface area to volume ratio which could affect the rate of perchlorate degradation. 
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Figure 24 (cont.) 
a 
b 
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Figure 24: TEM Images of Polymer Vesicles.  
a) OmpF vesicles are spherical and relatively uniform in size. b) No OmpF vesicles still have 
detergent in the sample that allows the formation of uniform spherical shapes. The No OmpF 
sample has a larger range of vesicle sizes compared to OmpF. c) No OmpF, No Detergent 
vesicles are irregular shaped forming worm-like structures.  
 
  
c 
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The reducing activity of the polymer vesicles was determined using the methyl viologen 
assay (Figure 25). As with lipid vesicles, the polymer vesicle experiments showed significantly 
reduced activities compared to soluble protein fraction assay values. As detailed in the 
Discussion, this is likely due to the very limited perchlorate-reducing volume created in the 
vesicles. Background activity was observed in the OmpF control containing no perchlorate due 
to minute traces of oxygen and the innate reducing power of the soluble protein fraction. This 
background activity value was subtracted from vesicle-reducing activity. Most importantly, 
OmpF vesicles had statistically higher activity than No OmpF vesicles overall (n=3 
P=0.0028).This trend was seen in lipids; however, lipid vesicles had lower activities compared to 
polymer vesicles. OmpF and No OmpF, No Detergent vesicles were also statistically different 
(n=3 P=0.000096). OmpF and No OmpF vesicles with detergent were also exposed to Proteinase 
K to determine the polymers ability to protect the enzymes inside the vesicles. A decline in the 
activity from protease treatment was noticed but was not statistically significant (n=3 P=0.088). 
This decrease could be a loss of activity resulting from the incubation at 25°C for one hour. Also, 
any remaining extra-vesicular enzymes could have been degraded by the protease.  
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Figure 25: Reducing Activity of Polymer Vesicles.  
Perchlorate reduction was observed in the polymer vesicles. OmpF vesicles were capable of 
degrading perchlorate at higher rates than No OmpF and No OmpF, No Detergent vesicles. 
OmpF vesicles maintain their ability to degrade perchlorate in the presence of protease. 
Background activity due to oxygen and reducing power of soluble protein fraction was measured 
and subtracted from activity values. Measurements were taken from biological triplicates and 
error bars represent standard deviation.  
 
 Observation of perchlorate-reducing activity implies perchlorate diffusion into and 
permeability of the vesicles. To measure the permeability of the vesicles to water, stopped-flow 
analysis was performed using a hyperosmotic 1 molar solution of sucrose (Figure 26). Vesicles 
were combined with an equal volume of osmotic solution. The rate of vesicles shrinkage was 
determined from light scattering.  The data was fit exponentially to give the k value. The k value 
was used to determine permeability values from Equation 1. 
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Figure 26: Typical Stopped Flow Data.  
The stopped flow data registers a sharp drop in light scattering in the initial mixture of the 
vesicles and osmotic solution.  The vesicles shrink from water leaving the vesicles causing light 
to scatter. The rise in scattered light is fitted exponentially and the rate of rise is determined, k.  
 
 The permeability of the vesicles was determined from using Equation 1 (Figure 27). 
OmpF, No OmpF and No OmpF, No Detergent vesicles were stored for approximately one 
month prior to measurement. An additional sample, ABA3 vesicles, was included. This sample 
was prepared by rehydrating in buffer with detergent. The permeability for all vesicles is very 
similar. This could be the result of the age of the vesicles and loss of OmpF and native porins.  
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Figure 27: Permeability of Polymer Vesicles.  
The permeability of the polymer vesicles to water were very similar suggesting that the number 
of OmpF and A. oryzae native porins inserted into the polymer was very low or the one-month 
old samples were losing permeability. 
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CHAPTER 5 – DISCUSSION AND CONCLUSION 
 
 This research created synthetic vesicles and assessed their ability to degrade perchlorate 
in a drinking water relevant aqueous environment. Perchlorate-reducing vesicles were created 
under laboratory conditions. The vesicle membrane was made with either natural lipids or 
manmade polymer. The outer membrane pore, OmpF, was inserted in the membrane material to 
act as a channel for perchlorate to diffuse in and out of the synthetic vesicles. Finally, partially 
purified perchlorate-reducing enzymes, Pcr and Cld, were encapsulated in the vesicles. This 
approach to perchlorate treatment uniquely combines manmade material and biological 
components. The approach also offers potential advantages over existing perchlorate treatment 
technologies. This thesis presents proof of concept for a novel treatment technology. 
 
The unique abilities of biological enzymes, such as Pcr and Cld, to reduce targeted 
contaminants offer engineers a variety of tools for the treatment purposes. However, cells often 
have goals counter to the engineers’. Cells often require very specific conditions in which to 
grow. Anything that may disturb the growth of the organism such as a change in electron donor 
or acceptor, temperature or agitation could reduce the elimination of contaminants.  By isolating 
and purifying the tool used for cleanup, scientists may be better able to control the cleanup 
process in order to achieve a specific goal. This research offers a method to accomplish those 
goals by allowing engineers to take biologically developed tools such as contaminant-degrading 
enzymes and encapsulate the enzymes in a synthetic vesicle. Once formed, the vesicles are 
introduced into the targeted contaminant area. Contaminants diffuse or are transported into the 
synthetic vesicles where enzymes turn the contaminant into an innocuous substance. The unique 
approach of combining synthetic and biological materials for the elimination of a contaminant 
has been successfully shown for perchlorate in this thesis.  
 
 This unique approach may have advantages over current treatment technologies for 
drinking water applications. For perchlorate, many of the drinking water treatment technologies 
have limitations associated with removal of concentrated waste, slow kinetics and unreliability. 
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For separation technologies such as GAC, IC and membranes, the drawback with these 
technologies is the associated concentrated wastes. The synthetic vesicle technology circumvents 
this problem by degrading perchlorate into chloride.  Perchlorate-degrading technologies such as 
chemical and biological reduction are limited by the use of heavy metals, slow kinetics, and 
fastidious environmental conditions respectively.  While the enzymes in synthetic vesicles 
contain heavy metals, the metals are in the interior of the vesicles which are easily contained by 
membranes. The kinetics of the vesicles at this time are slow; however, optimization of the 
diffusion of perchlorate into the vesicles and creating a column with a high concentration of 
these vesicles should improve the kinetics of perchlorate degradation. Finally, since the enzymes 
associated with perchlorate degradation are no longer in living cells, many of the environmental 
conditions required for biological reduction, such as absence of oxygen and nitrate, are no longer 
necessary. 
 
Despite the potential advantages this treatment technology has over current treatment 
technologies, this is a novel approach to water treatment. As such, significant research lies ahead 
before this system could be applied. This thesis has made progress on four key areas: (I) 
stabilizing the perchlorate-reducing enzymes in water treatment relevant aqueous conditions, (II) 
understanding the enzymes’ susceptibility to simulated microbial degradation using proteases, 
(III) studying the competitive effects of similar anions and (IV) exploring potential reasons for 
the limited perchlorate degradation rates seen in vesicles. However, for each of these items, 
additional work needs to be conducted to answer remaining concerns.  
 
I) Stabilization of perchlorate-reducing enzymes. 
 
Preparation of the soluble protein fraction, containing the perchlorate-reducing enzymes, 
Pcr and Cld, in aerobic environments did not affect the activities of the enzymes compared to 
anaerobic preparation. Also, 10% glycerol was found to extend the enzymes half-life 
significantly over a two-day period. Previous research demonstrated enzymes’ losing activity 
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with exposure to oxygen, with stabilization by the addition of 10% glycerol [51], while other 
research demonstrated that the deterioration of enzymatic activity occurred irrespective of 
oxygen presence [59].The difference in the effects of oxygen exposure and the glycerol 
stabilizing effect is likely caused by the use of different bacteria. Stabilizing the enzymes over 
time was essential in the formation of vesicles. Loss of significant portions of enzymatic activity 
over three days could result in vesicles with no functioning enzymes. Also, the application of the 
vesicles in the treatment of perchlorate-contaminated drinking water requires functionality in the 
order of months. For application in drinking water treatment, further research into increasing the 
half-life of the enzymes must be conducted. Experiments could include storing enzymes in 
perchlorate and electron donor to protect functional sites.  
 
II) Determination of the Effects of Protease Inhibitors and Proteinase K. 
 
Surprisingly, addition of a broad-spectrum protease inhibitor resulted in decreased 
enzyme activity. One possible explanation includes the potential protective nature of native 
proteases to perchlorate-reducing enzymes. The native proteases may be responsible for 
inactivation of Pcr and Cld degrading enzymes. To answer this question, future experiments 
could examine the possibility of an Azospira oryzae native protease responsible for perchlorate-
reducing enzyme protection. Also unexpected, treatment with the Proteinase K did not result in 
complete inactivation of the enzymes. This is likely due to the use of protease concentrations and 
exposure time less than recommended. The enzymes’ susceptibility to protease should be 
examined using higher protease concentrations, extended incubation times and varying 
incubation temperatures.  
 
III) Competition of Similar Anions. 
 
The enzymes responsible for perchlorate reduction were tested for reductive abilities 
against sulfate and nitrate due to these anions’ common inhibitory effect on current perchlorate 
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treatment technologies. The soluble protein fraction was able to reduce perchlorate and nitrate 
but not sulfate. The soluble protein fraction’s ability to reduce nitrate even at low rates is not 
desired. This is due to the presence of nitrate in drinking waters generally at concentrations in the 
ppm range whereas perchlorate concentrations are less than 100 ppb [78]. The competitive nature 
of the enzymatic enzymes for perchlorate and nitrate was assessed. Although both nitrate and 
perchlorate were reduced in environments where the anions concentrations were similar, the 
enzymes in the soluble protein fraction had greater affinity for perchlorate. Significant additional 
work should be conducted to verify perchlorate reduction in the presence of excess nitrate. These 
experiments should be conducted with anion ratios similar to those found in drinking water 
systems. Depending on these results, perchlorate-reducing enzymes from Azospria oryzae may 
not be an ideal candidate for use in synthetic perchlorate-reducing vesicles. Other bacteria unable 
to grow on nitrate may present a better alternative. Additional anions such as selenate, borate, 
iodate, and carbonate should also be assessed for activity with perchlorate reductase and chlorite 
dismutase. It is interesting to note that the chlorate and chlorite intermediates did not form 
suggesting that once the enzyme, Pcr, encounters perchlorate; it sequentially reduces perchlorate 
to chlorite without releasing the anion in the intermediate step. Chlorite, with its reduction 
having been previously shown to be independent of an electron donor [62], did not accumulate in 
the experiments.  
 
IV) Exploration of the Reasons For Limited Perchlorate-Degradation 
 The results of this thesis suggest that synthetic cells are capable of reducing perchlorate 
into chloride. The main issue remaining is the optimization of these perchlorate-reducing 
vesicles. The activity of the vesicles was significantly reduced compared to enzyme lysates. 
Possible explanations include inefficient enzyme encapsulation and limited perchlorate diffusion. 
As an initial assessment, the theoretical consequences of both potential limitations were 
calculated as detailed in Appendix C.  
The first set of equations examines the volume of vesicles when using 12 mg of polymer.  
As seen in the calculations, volume of the vesicles could be a limiting factor as theoretical 
calculations put perchlorate-reducing activity at a 2 fold higher rate, 149 Units/Liter, than 
obtained experimentally. This value is very similar to experimental values and could explain the 
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lower perchlorate-reducing vesicle activity compared to the soluble protein fraction. The small 
discrepancy between the volume encapsulation calculations and experimental values could be 
inefficient or preferential encapsulation of enzymes. Also, the theoretical calculations performed 
may fail to take into account several factors including lost polymer and release of enzymes 
during extrusion and size exclusion. Heterologous overexpression of both perchlorate reductase 
and chlorite dismutase would assure a higher concentration of perchlorate-reducing enzymes are 
encapsulated and provide additional data on perchlorate-reducing reaction rates.   
 
In additional to volume encapsulation calculations, perchlorate diffusion through OmpF 
into polymer vesicles was calculated using Fick’s Law and surface area calculations. The activity 
that could result from perchlorate diffusion is 4,910,000 U/L. This calculated activity 
demonstrates that transport of perchlorate into the vesicles does not seem to be the limiting 
factor. Even with hindered diffusion, which could reduce flux by 99%, the rate at which 
perchlorate enters the vesicles is sufficient to maintain higher levels of activity than were 
observed by 5 orders of magnitude. Volume limitation is therefore most likely to restrict the level 
of enzyme activity seen in my research.  
 
 Optimizing these synthetic vesicles to increase perchlorate reduction rates could 
eliminate a major hurdle in the application of this treatment technology. The use of these vesicles 
also presents many advantages over current treatment technologies as outlined previously. In this 
thesis, I have demonstrated the synthetic vesicles abilities’ to reduce perchlorate in relevant 
drinking water treatment conditions. The vesicles are able to protect the encapsulated enzymes 
from degradation associated with proteases. This work has also created the framework for 
producing vesicles capable of targeting other contaminants by selecting biological contaminant-
specific degrading enzymes.   
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APPENDIX A  
Anaerobic Growth Media 
Ralph S. Tanner (RST) Basal Media for Azospira oryzae (ATTC BAA-33) Growth 
 
RST Basal Medium                  (L
-1
) 
RST Mineral Stock Solution   20 ml 
RST Trace Metal Stock Solution  10 ml 
RST Vitamin Stock Solution   10 ml 
TES buffer     4.6 g 
NaHCO3     1.0 g 
Yeast extract     1.0 g 
NaCH3COOH     2.0 g 
NaClO4     1.0 g 
 
Adjust pH to 7.2 with 10N NaOH 
 
Volumes less than 100 ml: 
Cap and crimp seal bottles 
Exchange headspace 3 times with UHP N2 (10 psi) 
Autoclave 120°C 15 min 
 
Volumes greater than 100 ml: 
Autoclave 120°C 20 min uncapped 
Cap and crimp seal bottles while hot 
Using sterile cotton filters, exchange headspace 3 times with UHP N2 (5 psi) while hot 
 
The larger the volume the longer a vacuum should be applied to the media: 
 Less than 100 ml 30 min, 15 min and 5 min 
 Greater than 100 ml 1hr, 30 min, and 15 min (while hot) 
 
Note: A 1L culture grown to an OD of ~0.35 at 600 nm will yield ~1 g of A. oryzae (wet weight). 
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RST Stock Solutions 
 
RST Mineral Stock Solution  (L
-1
) 
NaCl      40 g 
NH4Cl      50 g 
KCl      5.0 g 
KH2PO4     5.0 g 
MgSO4 • 7H2O    10 g 
CaCl2 • 2H2O     1.0 g 
 
RST Trace Metal Stock Solution  (L
-1
) 
Nitrilotriacetic acid (pH 6.0 w/ KOH) 2.0 g 
MnSO4 • 2H2O    1.0 g 
Fe(NH4)2(SO4)2 • 6H2O   0.8 g 
CoCl2 • 6H2O     0.2 g 
ZnSO4 • 6H2O     0.2 g 
CuCl2 • 2H2O     20 mg 
NiCl2 • 6H2O      20 mg 
Na2SeO4     20 mg 
Na2WO4 • 2H2O    20 mg 
Na2MoO4 • 2H2O    20 mg 
 
RST Vitamin Stock Solution  (L
-1
) 
Pyridoxine HCl    10 mg 
Riboflavin     5.0 mg 
Calcium pantothenate    5.0 mg 
PABA      5.0 mg 
Thioctic acid     5.0 mg 
Niacinamide     5.0 mg 
Biotin      2.0 mg 
Folic acid     2.0 mg 
Vitamin B12     5.0 mg 
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APPENDIX B 
Table 1: Summarizing Perchlorate Activity of Cell Lysate (CL), Soluble Protein Fraction 
(SPF) and Vesicles. 
Cell Growth 
Date 
Test Date Sample Activity (U/L) 
6/8/2011 6/18/2011 Anaerobic CL Preparation 41680.7 
6/8/2011 6/18/2011 Anaerobic CL Preparation 45927.2 
6/8/2011 6/18/2011 Anaerobic CL Preparation 54407.147 
6/8/2011 6/18/2011 Anaerobic CL Control 511.16 
6/8/2011 6/18/2011 Anaerobic CL Control 367.34 
6/8/2011 6/18/2011 Anaerobic CL Control 1206.27 
6/8/2011 6/18/2011 Aerobic CL Preparation 40805.77 
6/8/2011 6/18/2011 Aerobic CL Preparation 52687.18 
6/8/2011 6/18/2011 Aerobic CL Preparation 45733.52 
6/8/2011 6/18/2011 Aerobic CL Control 444.47 
6/8/2011 6/18/2011 Aerobic CL Control 363.11 
6/8/2011 6/18/2011 Aerobic CL Control 157.28 
  6/18/2011 Perchlorate Only Control 94.51 
  6/18/2011 Perchlorate Only Control 31.04 
  6/18/2011 Perchlorate Only Control 47.92 
1/27/2011 4/15/2011 10% Glycerol Stabilization of SPF 22928.41 
1/31/2011 4/15/2011 10% Glycerol Stabilization of SPF 26671.43 
2/18/2011 4/15/2011 10% Glycerol Stabilization of SPF 26728.589 
1/27/2011 4/15/2011 10% Glycerol Stabilization of SPF 
Control 
386.14 
1/31/2011 4/15/2011 10% Glycerol Stabilization of SPF 
Control 
354.95 
2/18/2011 4/15/2011 10% Glycerol Stabilization of SPF 
Control 
360.54 
1/27/2011 4/15/2011 Stabilization of SPF 24363.16 
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Table 1 (cont.) 
1/31/2011 4/15/2011 Stabilization of SPF 29931.54 
2/18/2011 4/15/2011 Stabilization of SPF 25437.82 
1/27/2011 4/15/2011 Stabilization of SPF Control 692.66 
1/31/2011 4/15/2011 Stabilization of SPF Control 315.43 
2/18/2011 4/15/2011 Stabilization of SPF Control 455.41 
1/31/2011 7/29/2011 10% Glycerol Stabilization of SPF After 2 
Days 
18886.71 
2/18/2011 7/29/2011 10% Glycerol Stabilization of SPF After 2 
Days 
19475.78 
2/25/2011 7/29/2011 10% Glycerol Stabilization of SPF After 2 
Days 
17854.73 
1/31/2011 7/29/2011 10% Glycerol Stabilization of SPF After 2 
Days Control 
455.41 
2/18/2011 7/29/2011 10% Glycerol Stabilization of SPF After 2 
Days Control 
286.47 
2/25/2011 7/29/2011 10% Glycerol Stabilization of SPF After 2 
Days Control 
261.68 
1/31/2011 7/29/2011 Stabilization of SPF After 2 Day 9896.1 
2/18/2011 7/29/2011 Stabilization of SPF After 2 Day 9884.4 
2/25/2011 7/29/2011 Stabilization of SPF After 2 Day 8851.26 
1/31/2011 7/29/2011 Stabilization of SPF Control After 2 Days 168.36 
2/18/2011 7/29/2011 Stabilization of SPF Control After 2 Days 149.39 
2/25/2011 7/29/2011 Stabilization of SPF Control After 2 Days 155.46 
3/1/2011 9/14/2011 Protease Treatment SPF 3226.99 
2/25/2011 9/14/2011 Protease Treatment SPF 2809.38 
2/18/2011 9/14/2011 Protease Treatment SPF 3001.6545 
3/1/2011 9/14/2011 Protease Treatment SPF Control 142.84 
2/25/2011 9/14/2011 Protease Treatment SPF Control 118.67 
2/18/2011 9/14/2011 Protease Treatment SPF Control 130.46 
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Table 1 (cont.) 
3/1/2011 9/14/2011 No Protease Treatment  SPF 4082.17 
2/25/2011 9/14/2011 No Protease Treatment  SPF 4403.62 
2/18/2011 9/14/2011 No Protease Treatment  SPF 4202.62 
3/1/2011 9/14/2011 No Protease Treatment  SPF Control 75.86 
2/25/2011 9/14/2011 No Protease Treatment  SPF Control 117.5 
2/18/2011 9/14/2011 No Protease Treatment  SPF Control 94.35 
4/1/2011 2/1/2012 Protease Inhibitor SPF 2471.16 
6/5/2011 2/1/2012 Protease Inhibitor SPF 2543.64 
4/1/2011 2/1/2012 Protease Inhibitor SPF Control 309.8 
6/5/2011 2/1/2012 Protease Inhibitor SPF Control 322.28 
4/1/2011 2/1/2012 No Protease Inhibitor SPF 2936.43 
6/5/2011 2/1/2012 No Protease Inhibitor SPF 2766.22 
4/1/2011 2/1/2012 No Protease Inhibitor SPF Control 286.28 
6/5/2011 2/1/2012 No Protease Inhibitor SPF Control 355.27 
2/25/2011 7/29/2011 Lipid OmpF Vesicle 51.55 
5/2/2011 11/21/2011 Lipid OmpF Vesicle 38.85 
5/23/2011 12/18/2011 Lipid OmpF Vesicle 38.61 
2/25/2011 7/29/2011 Lipid OmpF Vesicle Control 3.45 
5/2/2011 11/21/2011 Lipid OmpF Vesicle Control 5.52 
5/23/2011 12/18/2011 Lipid OmpF Vesicle Control 5.03 
2/25/2011 7/29/2011 Lipid No OmpF 30.14 
5/2/2011 11/21/2011 Lipid No OmpF 17.44 
5/23/2011 12/18/2011 Lipid No OmpF 7.78 
2/25/2011 7/29/2011 Lipid OmpF Vesicle Protease 54.57 
5/2/2011 11/21/2011 Lipid OmpF Vesicle Protease 59.54 
5/23/2011 12/18/2011 Lipid OmpF Vesicle Protease 30.25 
2/25/2011 7/29/2011 Lipid OmpF Vesicle Protease Control 2.59 
5/2/2011 11/21/2011 Lipid OmpF Vesicle Protease Control 1.49 
5/23/2011 12/18/2011 Lipid OmpF Vesicle Protease Control 6.29 
70 
 
Table 1 (cont.) 
6/5/2011 2/3/2012 Polymer OmpF Vesicle 64.96 
2/2/2012 2/15/2012 Polymer OmpF Vesicle 70.22 
3/18/2012 3/26/2012 Polymer OmpF Vesicle 76.8 
6/5/2011 2/3/2012 Polymer No OmpF Vesicles 38.87 
2/2/2012 2/15/2012 Polymer No OmpF Vesicles 50.73 
3/18/2012 3/26/2012 Polymer No OmpF Vesicles 41.41 
6/5/2011 2/3/2012 Polymer No OmpF No Detergent Vesicles 20.31 
2/2/2012 2/15/2012 Polymer No OmpF No Detergent Vesicles 24.34 
3/18/2012 3/26/2012 Polymer No OmpF No Detergent Vesicles 23.47 
6/5/2011 2/3/2012 Polymer OmpF Protease Vesicles 62.29 
2/2/2012 2/15/2012 Polymer OmpF Protease Vesicles 54.89 
3/18/2012 3/26/2012 Polymer OmpF Protease Vesicles 64.51 
6/5/2011 2/3/2012 Polymer No OmpF Protease Vesicles 43.65 
2/2/2012 2/15/2012 Polymer No OmpF Protease Vesicles 41.66 
3/18/2012 3/26/2012 Polymer No OmpF Protease Vesicles 30.14 
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APPENDIX C 
Calculations of Theoretical Vesicle Activity. The activity of the vesicles was much lower than 
soluble protein fraction.  To determine the possible causes of this reduction in activity, 
theoretical calculations of the vesicles’ activity were performed with respect to 1) the total 
volume activity (TVA) restriction of the vesicle determined by the encapsulation volume of the 
perchlorate-reducing vesicles and 2) the diffusion limited activity (DLA) determined by the 
perchlorate diffusion across OmpF in the polymer membrane. Several assumptions went into 
these calculations and were included at appropriate points in the calculations  
 
1. ENCAPSULATION VOLUME RESTRICTION ON ACTIVITY 
 
The total volume activity (TVA) was calculated using Equation 3. 
 
     
       
   
 (1) 
 
Equation 3: Volume Restriction on Vesicle Activity. 
The theoretical total volume activity (TVA) was calculated using the total vesicle encapsulation 
volume (TEV), the activity of the soluble protein fraction (APF), and the total suspension 
volume of vesicle (TVV) after preparation using size exclusion chromatography. 
 
The TEV was calculated by determining the total number of vesicles (TNV) and the 
encapsulation volume of one vesicle (EV). 
 
            (2) 
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The Total Number of Vesicles (TNV) was difficult to determine from dynamic light 
scattering results due to their small size. So, the TNV was calculated using the mass of polymer, 
the surface area (SA) of a polymer molecule, and the surface area of a vesicle. This calculation 
assumed that all polymer molecules were incorporated into vesicles. This assumption was made 
as the experiments were not designed to account for polymer lost during vesicle preparation 
which included extrusion and size exclusion. 
 
     
                                      
              
 (3) 
 
The number of polymer molecules was determined from the experimental mass of 
polymer, 12 mg. This value was converted to the total number of polymer molecules using the 
gram formula mass of 11048 mg/mmol calculated from the polymer structure (Figure 3).  
 
                
     
       
 
    
        
                      (4) 
 
The total number of polymer molecules was calculated using the moles of polymer and 
Avogadro’s number. 
 
                       
         
   
                           (5) 
 
The surface area of a polymer molecule was 350 Å
2 
[79]. This value was determined 
experimentally; however, the value was obtained from a reported range of values, 200 to 500 Å
2
. 
In addition, the polymer used in the published experiment contained block number, A16B74A16, 
which is smaller than the polymer used in the experiments of this thesis. The surface area of a 
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vesicle was determined using geometrical equation for the surface area of a sphere and the 
assumed diameter of 180 nm (a radius of 90 nm). The diameter of the vesicles was determined 
using dynamic light scattering.  The radius was an average value and for these calculations, all 
vesicles are assumed to have a uniform vesicle diameter of 180 nm. 
 
               
   
        
                    (6) 
 
 The TNV was calculated using equation line (3). 
 
 
                             (
  
               
)
        (
  
       
)
                   (7) 
 
The encapsulation volume (EV) of a vesicle was determined from the geometrical 
equation of volume for a sphere.  The inner diameter of the vesicle was used. The inner diameter 
of the vesicle was determined from light scattering and the thickness of the polymer, 15 nm. The 
inner diameter used in these calculations was 150 nm.  
 
 
 
 
   
         
       
 
         
    
 
     
   
                     (8) 
 
 
From equation line (2), the TEV was calculated.  
 
             
 
       
                              (9) 
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Having calculated the total encapsulation volume (TEV), the APF and TVV from 
equation line (1) was determined next. The APF was calculated assuming the encapsulation 
volume contained uniform activity similar to the soluble protein fraction. The activities from 
soluble protein fraction used to prepare the vesicle in experiments performed in this thesis ranged 
from 5000 to 15,000 U/L. For these calculations, the activity was assumed at 15,000 U/L in order 
to calculate a theoretical maximum. The most direct means of calculating vesicle concentrations 
was not available during these experiments.  Since a method was not available, the total vesicle 
suspension volume (TVV) was used with the total number of vesicles to determine an 
approximate concentration.  This value was obtained after vesicle preparation including 
extrusion and size exclusion chromatography. During size exclusion chromatography, the 
separation of vesicles from the soluble protein fractions resulted in an unknown dilution. 
However, the volume of the vesicle suspension was determined from size exclusion 
chromatography. This volume, TVV, was used to determine limitations of the total volume 
activity (TVA)  
 
     
           (      (
 
 
))
      
        (10) 
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2. PERCHLORATE DIFFUSION RESTRICTION ON ACTIVITY 
 
The diffusion limiting activity (DLA) was calculated using Equation 4.  
 
     
     
   
 (11) 
 
Equation 4: Diffusion Limiting Activity. 
The diffusion limiting activity was determined using the flux of perchlorate (F), the surface area 
of the vesicles (SAV), and the total vesicle suspension volume (TVV). 
 
        
  
  
 (12) 
 
Equation 5: Fick’s First Law for Diffusion.  
The flux of perchlorate was determined from the diffusion coefficient (D), the porosity of the 
vesicles (n), and the perchlorate concentration gradient (dC/dx). 
 
For perchlorate, the diffusion coefficient (D) was determined as 2.25 X 10
-5 
cm
2
/s [80]. 
The equations were further adapted to account for the pore structure of the vesicles. Perchlorate 
should only be able to diffuse into the vesicles through pores. While data suggest that the 
vesicles were permeable through the polymer, for now, I assumed that flux can only occur 
though the OmpF. Also, I assumed flux of perchlorate into the pore was not hindered by steric 
effects. The calculations assumed 100% insertion efficiency of the 1:200 molar ratio of OmpF to 
polymer. Experiments were not designed to determine the insertion efficiency of the OmpF. The 
porosity of the vesicle, a unitless value, was determined from the ratio of OmpF surface area to 
vesicle surface area and molar ratio. The dimensions of the pore were given as 7Å by 11Å [81]. 
The surface area of the elliptical OmpF was 60.5 Å
2
.  
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          (13) 
 
The concentration gradient (dC/dx) was determined by the perchlorate concentration used 
in the experiments (0.83 µmole/cm
3
) over the radius of the vesicle. The radius of the vesicle was 
used rather than the thickness of the membrane to account for the laminar layer that surrounds 
the vesicle. The flux of perchlorate (F) was determined using equation line (12). 
 
 
         (
   
 
)          (     (
    
   
))
           
       (
    
      
) (14) 
 
The flux of perchlorate was converted to µmoles of methyl viologen consumed per minute to 
make units consistent with previous activity values. Four moles of methyl viologen are required 
to convert perchlorate into chlorite. Chlorite exchanges electrons intramolecularly to form 
chloride and diatomic oxygen. Oxygen consumes an additional four moles of methyl viologen to 
form water. Together, perchlorate consumes eight moles of methyl viologen (MV).  
 
        
         
 
     
 
       
         
  
   
   
      
      
       
 (15) 
 
Having determined the flux of perchlorate (F), the total surface area of the vesicles was 
calculated using the surface area of one vesicle and the total number of vesicles as previously 
calculated in equation lines (6) and (7).  
 
         
 
 
       
                  
    
     
          
  (16) 
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 The final calculation used equation line (11) to determine the activity of vesicles when 
considering diffusion of perchlorate into the vesicle. 
 
 
     
    
       
          
      
             (17) 
 
 See the Discussion for comparison of the vesicle encapsulation and perchlorate diffusion 
limitations on perchlorate degradation.  
